{
    "paper_id": "xml_output_cochrane\\Barbosa_et_al-2021-Cochrane_Database_of_Systematic_Reviews",
    "header": {
        "generated_with": "S2ORC 1.0.0",
        "date_generated": "2024-04-05T17:20:05.880382Z"
    },
    "title": "Non-invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea",
    "authors": [
        {
            "first": "Frederico",
            "middle": [
                "T"
            ],
            "last": "Barbosa",
            "suffix": "",
            "affiliation": {
                "laboratory": "",
                "institution": "Universidade Federal de S\u00e3o Paulo",
                "location": {
                    "settlement": "Sao Paulo",
                    "country": "Brazil"
                }
            },
            "email": ""
        },
        {
            "first": "Michele",
            "middle": [
                "P"
            ],
            "last": "Silva",
            "suffix": "",
            "affiliation": {
                "laboratory": "",
                "institution": "Alcides Carneiro Hospital",
                "location": {
                    "settlement": "Petropolis",
                    "country": "Brazil"
                }
            },
            "email": ""
        },
        {
            "first": "Lu\u00eds",
            "middle": [
                "Eduardo S"
            ],
            "last": "Fontes",
            "suffix": "",
            "affiliation": {
                "laboratory": "",
                "institution": "Cochrane Afilliate Rio de Janeiro",
                "location": {
                    "settlement": "Cochrane, Petr\u00f3polis",
                    "country": "Brazil"
                }
            },
            "email": ""
        },
        {
            "first": "Daniela",
            "middle": [
                "V"
            ],
            "last": "Pachito",
            "suffix": "",
            "affiliation": {
                "laboratory": "",
                "institution": "Hospital Sirio-Liban\u00eas",
                "location": {
                    "settlement": "S\u00e3o Paulo",
                    "country": "Brazil"
                }
            },
            "email": ""
        },
        {
            "first": "Tamara",
            "middle": [],
            "last": "Melnik",
            "suffix": "",
            "affiliation": {
                "laboratory": "",
                "institution": "Cochrane Brazil",
                "location": {
                    "settlement": "S\u00e3o Paulo",
                    "country": "Brazil"
                }
            },
            "email": ""
        },
        {
            "first": "Rachel",
            "middle": [],
            "last": "Riera",
            "suffix": "",
            "affiliation": {
                "laboratory": "",
                "institution": "Cochrane Afilliate Rio de Janeiro",
                "location": {
                    "settlement": "Cochrane, Petr\u00f3polis",
                    "country": "Brazil"
                }
            },
            "email": ""
        }
    ],
    "year": "",
    "venue": null,
    "identifiers": {},
    "abstract": "Non-invasive positive airway",
    "pdf_parse": {
        "paper_id": "xml_output_cochrane\\Barbosa_et_al-2021-Cochrane_Database_of_Systematic_Reviews",
        "_pdf_hash": "",
        "doi": "10.1002/14651858.cd013169.pub2",
        "keywords": [],
        "abstract": [
            {
                "text": "Non-invasive positive airway",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Abstract",
                "sec_num": null
            }
        ],
        "body_text": [
            {
                "text": "Obstructive sleep apnoea syndrome (OSAS) is associated with several chronic diseases, including erectile dysfunction (ED).The association of OSAS and ED is far more common than might be found by chance; the treatment of OSAS with non-invasive positive airway pressure therapy is associated with improvement of respiratory symptoms, and may contribute to the improvement of associated conditions, such as ED.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Background",
                "sec_num": null
            },
            {
                "text": "To assess the e ectiveness and acceptability of non-invasive positive airway pressure therapy for improving erectile dysfunction in OSAS.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Objectives",
                "sec_num": null
            },
            {
                "text": "We identified studies from the Cochrane Airways Trials Register, CENTRAL, MEDLINE, Embase, PsycINFO, CINAHL, AMED EBSCO, and LILACS, the US National Institutes of Health ongoing trials register ClinicalTrials.gov,and the World Health Organisation international clinical trials registry platform to 14 June 2021, with no restriction on date, language, or status of publication.We checked the reference lists of all primary studies, and review articles for additional references, and relevant manufacturers' websites for study information.We also searched specific conference proceedings for the British Association of Urological Surgeons; the European Association of Urology; and the American Urological Association to 14 June 2021.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Search methods",
                "sec_num": null
            },
            {
                "text": "We considered randomised controlled trials (RCTs) with a parallel or cross-over design, or cluster-RCTs, which included men aged 18 years or older, with OSAS and ED.We considered RCTs comparing any non-invasive positive airway pressure therapy (such as continuous positive airways pressure (CPAP), bilevel positive airway pressure (BiPAP), variable positive airway pressure (VPAP), or similar devices) versus sham, no treatment, waiting list, or pharmacological treatment for ED.The primary outcomes were remission of ED and serious adverse events; secondary outcome were sex-related quality of life, health-related quality of life, and minor adverse events.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Selection criteria",
                "sec_num": null
            },
            {
                "text": "Two review authors independently conducted study selection, data extraction, and risk of bias assessment.A third review author solved any disagreement.We used the Cochrane RoB 1 tool to assess the risk of bias of the included RCTs.We used the GRADE approach to assess the certainty of the body of evidence.To measure the treatment e ect on dichotomous outcomes, we used the risk ratio (RR); for continuous outcomes, we used the mean di erence (MD).We calculated 95% confidence intervals (CI) for these measures.When possible (data availability and homogeneous studies), we used a random-e ect model to pool data with a meta-analysis.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Data collection and analysis",
                "sec_num": null
            },
            {
                "text": "We included six RCTs (all assessing CPAP as the non-invasive positive airway pressure therapy device), with a total of 315 men with OSAS and ED.All RCTs presented some important risk of bias related to selection, performance, assessment, or reporting bias.None of included RCTs assessed the ED remission rate, and we used the provided ED mean scores as a proxy.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Main results",
                "sec_num": null
            },
            {
                "text": "There is uncertainty about the e ect of CPAP on mean ED scores a er 4 weeks, using the International index of erectile function (IIEF-5, higher = better; MD 7.50, 95% CI 4.05 to 10.95; 1 RCT; 27 participants; very low-certainty evidence), and a er 12 weeks (IIEF-ED, ED domain; MD 2.50, 95% CI -1.10 to 6.10; 1 RCT; 57 participants; very low-certainty evidence, downgraded due to methodological limitations and imprecision).There is uncertainty about the e ect of CPAP on sex-related quality of life a er 12 weeks, using the Self-esteem and relationship test (SEAR, higher = better; MD 1.00, 95% CI -8.09 to 10.09; 1 RCT; 57 participants; very low-certainty evidence, downgraded due to methodological limitations and imprecision); no serious adverse events were reported a er 4 weeks (1 RCT; 27 participants; very low-certainty evidence, downgraded due to methodological limitations and imprecision).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "CPAP versus no CPAP",
                "sec_num": null
            },
            {
                "text": "One RCT assessed this comparison (61 participants), but we were unable to extract outcomes for this comparison due to the factorial design and reporting of this trial.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "CPAP versus sham CPAP",
                "sec_num": null
            },
            {
                "text": "Sildenafil may slightly improve erectile function at 12 weeks when compared to CPAP, measured with the IIEF-ED (MD -4.78, 95% CI -6.98 to -2.58; 3 RCTs; 152 participants; I = 59%; low-certainty evidence, downgraded due to methodological limitations).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "CPAP versus sildenafil (phosphodiesterase type 5 inhibitors)",
                "sec_num": null
            },
            {
                "text": "There is uncertainty about the e ect of CPAP on sex-related quality of life a er 12 weeks, measured with the Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire (EDITS, higher = better; MD -1.24, 95% CI -1.80 to -0.67; 2 RCTs; 122 participants; I = 0%; very low-certainty evidence, downgraded due to methodological limitations).No serious adverse events were reported for either group (2 RCTs; 70 participants; very low-certainty evidence, downgraded due to methodological limitations and imprecision).There is uncertainty about the e ects of CPAP when compared to sildenafil for the incidence of minor adverse events (RR 1.33, 95% CI 0.34 to 5.21; 1 RCT; 40 participants; very low-certainty evidence, downgraded due to methodological limitations and imprecision).The confidence interval was wide and neither a significant increase nor reduction in the risk of minor adverse events can be ruled out with the use of CPAP (4/20 men complained of nasal dryness in the CPAP group, and 3/20 men complained of transient flushing and mild headache in the sildenafil group).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "CPAP versus sildenafil (phosphodiesterase type 5 inhibitors)",
                "sec_num": null
            },
            {
                "text": "When compared with no CPAP, we are uncertain about the e ectiveness and acceptability of CPAP for improving erectile dysfunction in men with obstructive sleep apnoea.When compared with sildenafil, there is some evidence that sildenafil may slightly improve erectile function at 12 weeks.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Authors' conclusions",
                "sec_num": null
            },
            {
                "text": "The purpose of this review was to assess the e ectiveness and acceptability of non-invasive positive airway pressure therapy for improving erectile dysfunction (ED) in men with obstructive sleep apnoea (OSAS).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Review question",
                "sec_num": null
            },
            {
                "text": "OSAS is a clinical condition in which repeated throat obstructions occur during sleep, leading to pauses in breathing.Erectile dysfunction is the inability of a man to achieve and maintain a su icient erection to allow satisfactory sexual activity.The association of OSAS and ED is far more common than might be found by chance.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Background",
                "sec_num": null
            },
            {
                "text": "Non-invasive positive airway pressure therapy is a device that is attached to a mask that delivers oxygen.The device helps air enter the airways and help breathing.There are a few di erent types of devices including continuous positive airway pressure (CPAP), bilevel The mean erectile dysfunction score with CPAP device was 2.5 points higher (1.1 lower to 6.We are very confident that the true effect lies close to that of the estimate of the effect.Moderate certainty.We are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.Low certainty.Our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.Very low certainty, We have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Background",
                "sec_num": null
            },
            {
                "text": "a High risk of bias for blinding participants, personal, outcome assessment; we downgraded two levels (-2).b No events were reported.c Small sample size; we downgraded one level (-1), d Wide 95% CI, including null e ect; we downgraded two levels (-2).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Comments",
                "sec_num": null
            },
            {
                "text": "Obstructive sleep apnoea syndrome (OSAS) is characterised by recurrent occlusion of the pharyngeal airway space (respiratory tract) during sleep (Eckert 2008) .OSAS is caused by a combination of factors, namely: obesity, increased upper airway resistance, craniofacial abnormalities, and failure of the dilator action of pharyngeal muscle (Eckert 2008) .OSAS is a highly prevalent condition, a ecting 14% of men and 5% of women (Peppard 2013) (the result of release of pro-inflammatory cytokines from immunerelated cells and the activation of the innate immune system), and increased activity of the sympathetic nervous system (Arnardottir 2009) .These mechanisms culminate in endothelial dysfunction (diminished production or availability of nitric oxide, or imbalance in the relative contribution of endothelium-derived relaxing and contracting factor, or both), and structural changes in vessels (Gunnarsson 2014) .As a consequence of this, OSAS leads to increase cardiovascular (Young 2008), and all-cause mortality (Marshall 2008; Wolf 2007) .",
                "cite_spans": [
                    {
                        "start": 145,
                        "end": 158,
                        "text": "(Eckert 2008)",
                        "ref_id": null
                    },
                    {
                        "start": 339,
                        "end": 352,
                        "text": "(Eckert 2008)",
                        "ref_id": null
                    },
                    {
                        "start": 428,
                        "end": 442,
                        "text": "(Peppard 2013)",
                        "ref_id": null
                    },
                    {
                        "start": 627,
                        "end": 645,
                        "text": "(Arnardottir 2009)",
                        "ref_id": "BIBREF1"
                    },
                    {
                        "start": 899,
                        "end": 916,
                        "text": "(Gunnarsson 2014)",
                        "ref_id": null
                    },
                    {
                        "start": 1020,
                        "end": 1035,
                        "text": "(Marshall 2008;",
                        "ref_id": null
                    },
                    {
                        "start": 1036,
                        "end": 1046,
                        "text": "Wolf 2007)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "B A C K G R O U N D Description of the condition",
                "sec_num": null
            },
            {
                "text": "Erectile dysfunction (ED) is defined by the persistent inability to achieve and maintain an erection su icient to permit satisfactory intercourse (APA 2013).Erectile dysfunction may result from one or more of the following aetiologies: psychological, neurologic, hormonal, arterial, and venous.ED can be classified as psychogenic, iatrogenic (injury or adverse e ect caused by the treatment), and organic (APA 2013; Muneer 2014; Shamloul 2013) .Organic impotence refers to the inability to obtain an erection firm enough for penetration, or the inability to sustain the erection until completion of intercourse.In contrast to psychogenic impotence (which is impotence caused by anxiety, guilt, depression, or conflict around various sexual issues), organic impotence, the more common of the three categories of erectile dysfunction, is caused by physical problems (Ende 1990) .ED is the most common cause of sexual dissatisfaction, a ecting up to 20% of men at all ages, and 50% to 60% of older men (Holden 2005; Rosen 2004 ).Psychological factors may influence ED, but an organic cause is identified in the majority of cases.Organic ED represents 60% to 80% of all cases, and is associated with systemic diseases, such as hypertension and diabetes (Lue 2000) .",
                "cite_spans": [
                    {
                        "start": 405,
                        "end": 415,
                        "text": "(APA 2013;",
                        "ref_id": null
                    },
                    {
                        "start": 416,
                        "end": 428,
                        "text": "Muneer 2014;",
                        "ref_id": null
                    },
                    {
                        "start": 429,
                        "end": 443,
                        "text": "Shamloul 2013)",
                        "ref_id": null
                    },
                    {
                        "start": 864,
                        "end": 875,
                        "text": "(Ende 1990)",
                        "ref_id": null
                    },
                    {
                        "start": 999,
                        "end": 1012,
                        "text": "(Holden 2005;",
                        "ref_id": null
                    },
                    {
                        "start": 1013,
                        "end": 1023,
                        "text": "Rosen 2004",
                        "ref_id": null
                    },
                    {
                        "start": 1249,
                        "end": 1259,
                        "text": "(Lue 2000)",
                        "ref_id": "BIBREF53"
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "B A C K G R O U N D Description of the condition",
                "sec_num": null
            },
            {
                "text": "The association of OSAS and ED is far more common than might be found by chance (Andersen 2010).The joint prevalence rate is estimated to be in the range of 30% to 70% (Santos 2012; Se el 2002) .OSAS severity, particularly when determined by the level of hypoxaemia, predicts the presence of erectile dysfunction (Shin 2008) .Both diseases are associated with chronic comorbidities, such as hypertension and diabetes, and share several risk factors in common, such as age and obesity.However, OSAS remains an independent predictor of ED in adjusted models, suggesting a causal relationship (Budweiser 2013) .",
                "cite_spans": [
                    {
                        "start": 168,
                        "end": 181,
                        "text": "(Santos 2012;",
                        "ref_id": null
                    },
                    {
                        "start": 182,
                        "end": 193,
                        "text": "Se el 2002)",
                        "ref_id": null
                    },
                    {
                        "start": 313,
                        "end": 324,
                        "text": "(Shin 2008)",
                        "ref_id": null
                    },
                    {
                        "start": 590,
                        "end": 606,
                        "text": "(Budweiser 2013)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "B A C K G R O U N D Description of the condition",
                "sec_num": null
            },
            {
                "text": "Non-invasive positive airway pressure therapy consists of the application of positive pressure in the airways, through a nasal or oronasal mask, to prevent the collapse of pharyngeal so tissues during sleep; it is associated with improved sleep, reduced excessive daytime sleepiness, and improved cognitive function (Jonas 2017; Jordan 2014) .",
                "cite_spans": [
                    {
                        "start": 316,
                        "end": 328,
                        "text": "(Jonas 2017;",
                        "ref_id": null
                    },
                    {
                        "start": 329,
                        "end": 341,
                        "text": "Jordan 2014)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Description of the intervention",
                "sec_num": null
            },
            {
                "text": "Continuous positive airway pressure (CPAP) is a non-invasive positive airway pressure device that is widely recognised as the first-line treatment for OSAS, due to its e ectiveness in reducing both the apnoea/hypopnoea index (AHI) and excessive daytime sleepiness (ESS), although low rates of adherence to CPAP are commonly observed in the long term (Epstein 2009; Giles 2006) .Non-adherence rates remain in the range of 30% to 40%, despite the technological advances in developing more comfortable interfaces and machines made by the industry (Rotenberg 2016) .Currently, there is no unequivocal recommendation about how many hours of CPAP is needed per night to improve symptoms related to OSAS, but a range of four to six hours has been suggested for di erent clinical outcomes (Weaver 2007).",
                "cite_spans": [
                    {
                        "start": 350,
                        "end": 364,
                        "text": "(Epstein 2009;",
                        "ref_id": null
                    },
                    {
                        "start": 365,
                        "end": 376,
                        "text": "Giles 2006)",
                        "ref_id": null
                    },
                    {
                        "start": 544,
                        "end": 560,
                        "text": "(Rotenberg 2016)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Description of the intervention",
                "sec_num": null
            },
            {
                "text": "To date, the literature has failed to demonstrate e ectiveness of CPAP on cardiovascular outcomes, but there is uncertainty for ED outcomes, perhaps due to the multiple potential mechanisms of action of CPAP on ED (Qiu 2017) .",
                "cite_spans": [
                    {
                        "start": 214,
                        "end": 224,
                        "text": "(Qiu 2017)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Description of the intervention",
                "sec_num": null
            },
            {
                "text": "One meta-analysis evaluated the e ect of CPAP on endothelial function in participants with OSAS (Xu 2015).A randome ects model found that CPAP significantly improved endothelial function, assessed by flow-mediated dilation (widening of an artery when blood flow increases in that artery), but there was no significant improvement in endothelial function in response to nitroglycerin-mediated dilation (organic nitrate with vasodilator activity).Sensitivity analyses indicated that the protective e ect of CPAP on endothelial function was robust.CPAP significantly improved flow-mediated dilatation in participants with OSAS (Xu 2015).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Description of the intervention",
                "sec_num": null
            },
            {
                "text": "Besides CPAP device, there are other devices available for noninvasive airways pressure therapy, as bilevel positive airway pressure (BiPAP) and variable positive airway pressure (VPAP), with similar mechanisms, that could be analysed.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Description of the intervention",
                "sec_num": null
            },
            {
                "text": "From the mechanistic perspective, the endothelial dysfunction caused by oxidative stress in people with OSAS may be the cause of the high prevalence rates of both OSAS and ED (Hoyos 2015) .",
                "cite_spans": [
                    {
                        "start": 175,
                        "end": 187,
                        "text": "(Hoyos 2015)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "How the intervention might work",
                "sec_num": null
            },
            {
                "text": "It has been clearly demonstrated that OSAS causes endothelial dysfunction, which in turn is a root cause of ED.Endothelial dysfunction reduces the secretion of nitric oxide, leading to impaired relaxation of smooth muscles, and consequently, to inadequate vasodilatation and lack of blood flow to the Cochrane Database of Systematic Reviews corpora cavernous.Other mechanisms have also been implied, such as sympathetic activation, rapid eye movement (REM) sleep fragmentation, hormonal deficiency, and mood disorders (Jeon 2015; Luboshitzky 2002) .Non-invasive positive airway pressure therapy reverses sleep fragmentation and intermittent hypoxaemia, which reduces oxidative stress (Alonso-Fernandez 2009), and also improves endothelial function (Schwarz 2015; Somers 1995) .Therefore, this therapy leads to the improvement of intermediate mechanisms, which might contribute to ED in people with OSAS.",
                "cite_spans": [
                    {
                        "start": 518,
                        "end": 529,
                        "text": "(Jeon 2015;",
                        "ref_id": null
                    },
                    {
                        "start": 530,
                        "end": 547,
                        "text": "Luboshitzky 2002)",
                        "ref_id": null
                    },
                    {
                        "start": 748,
                        "end": 762,
                        "text": "(Schwarz 2015;",
                        "ref_id": null
                    },
                    {
                        "start": 763,
                        "end": 775,
                        "text": "Somers 1995)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "How the intervention might work",
                "sec_num": null
            },
            {
                "text": "Erectile dysfunction impairs quality of life by compromising selfesteem, and by promoting emotional and relationship tension (Althof 2002) .OSAS also impacts negatively on quality of life, due to its neuropsychiatric symptoms, cognitive dysfunction, and disruption of professional and social life.Both conditions are highly prevalent in the general population (Feldman 1994; Pastore 2014 ).",
                "cite_spans": [
                    {
                        "start": 125,
                        "end": 138,
                        "text": "(Althof 2002)",
                        "ref_id": null
                    },
                    {
                        "start": 360,
                        "end": 374,
                        "text": "(Feldman 1994;",
                        "ref_id": null
                    },
                    {
                        "start": 375,
                        "end": 387,
                        "text": "Pastore 2014",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Why it is important to do this review",
                "sec_num": null
            },
            {
                "text": "Continuous positive airway pressure therapy is e ective in improving excessive daytime sleepiness (McDaid 2009 ), yet it is still not clear to what extent CPAP is capable of improving ED in people with OSAS, or whether it is more e ective than standard pharmacological treatment of ED (Dong 2010; Khafagy 2012) .",
                "cite_spans": [
                    {
                        "start": 98,
                        "end": 110,
                        "text": "(McDaid 2009",
                        "ref_id": null
                    },
                    {
                        "start": 285,
                        "end": 296,
                        "text": "(Dong 2010;",
                        "ref_id": null
                    },
                    {
                        "start": 297,
                        "end": 310,
                        "text": "Khafagy 2012)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Why it is important to do this review",
                "sec_num": null
            },
            {
                "text": "With the answer to this debate, the practical recommendations for approaching ED in OSAS might di er from the approach of ED in the general population.Whilst pharmacological treatment of ED with oral phosphodiesterase type 5 inhibitors is generally considered safe and e ective (Goldstein 2016) , some potentially harmful side e ects have been reported (Galvez-Ruiz 2013).",
                "cite_spans": [
                    {
                        "start": 278,
                        "end": 294,
                        "text": "(Goldstein 2016)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Why it is important to do this review",
                "sec_num": null
            },
            {
                "text": "This Cochrane Review is important, as it will systematically evaluate the e ectiveness of non-invasive positive airway pressure therapy in improving ED, and other important clinical outcomes, such as quality of life, in men with OSAS.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Why it is important to do this review",
                "sec_num": null
            },
            {
                "text": "To assess the e ectiveness and acceptability of non-invasive positive airway pressure for improving erectile dysfunction in obstructive sleep apnoea syndrome.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "O B J E C T I V E S",
                "sec_num": null
            },
            {
                "text": "We sought randomised controlled trials (RCTs) with a parallel or cross-over design, and cluster-RCTs.We included studies reported in full text, those published as an abstract only, and unpublished data.We included studies regardless of the date or language of publication.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Types of studies",
                "sec_num": null
            },
            {
                "text": "We considered studies with men, aged 18 years or older, with obstructive sleep apnoea syndrome (OSAS) and erectile dysfunction (ED).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Types of participants",
                "sec_num": null
            },
            {
                "text": "OSAS was defined by the occurrence of daytime sleepiness, loud snoring, witnessed breathing interruptions, or awakenings due to gasping or choking, in the presence of at least five obstructive respiratory events per hour of sleep (apnoeas, hypopnoeas, or respiratory e ort-related arousals), or alternatively, by the presence of 15 or more obstructive respiratory events per hour of sleep, even in the absence of clinical symptomatology (American Academy of Sleep Medicine 2014).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Diagnostic criteria for OSAS",
                "sec_num": null
            },
            {
                "text": "ED was defined by meeting criteria from one of these sources:",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Diagnostic criteria for ED",
                "sec_num": null
            },
            {
                "text": "\u2022 If any other validated diagnostic criteria were used, we also considered them for this review.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Diagnostic criteria for ED",
                "sec_num": null
            },
            {
                "text": "We investigated the following interventions and comparators.We included studies with any co-intervention, provided both groups (intervention and control) received the same cointervention, in the same way, so that the possible di erence in results was the e ect of the non-invasive positive airway pressure therapy.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Types of interventions",
                "sec_num": null
            },
            {
                "text": "The minimum duration of intervention was one month.We considered any length of follow-up.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Minimum duration of intervention and follow-up",
                "sec_num": null
            },
            {
                "text": "\u2022 Sex-related quality of life \u2022 Health-related quality of life \u2022 Minor adverse events Cochrane Database of Systematic Reviews the International Index of Erectile Function (IIEF) and the International Index of Erectile Function-5 (IIEF-5 (Rosen 1999) ).",
                "cite_spans": [
                    {
                        "start": 237,
                        "end": 249,
                        "text": "(Rosen 1999)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Secondary outcomes",
                "sec_num": null
            },
            {
                "text": "For the standard formal IIEF questionnaire, remission is defined as a score of 19 or more out of 30 points; for the IIEF-5 questionnaire, it is a score of 17 or more out of 25 points (Rosen 1999) .A brief explanation of each tool is presented in Appendix 1.",
                "cite_spans": [
                    {
                        "start": 183,
                        "end": 195,
                        "text": "(Rosen 1999)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Method and timing of outcome measurement",
                "sec_num": null
            },
            {
                "text": "\u2022 Serious adverse events: proportion of men with at least one serious adverse event related to CPAP use, such as pneumothorax, impairment of cardiac function in men with heart failure. 2000) ).",
                "cite_spans": [
                    {
                        "start": 185,
                        "end": 190,
                        "text": "2000)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Method and timing of outcome measurement",
                "sec_num": null
            },
            {
                "text": "\u2022 Minor adverse events: proportion of men with at least one minor adverse event (e.g.local allergy, local injury, nasal dryness).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Method and timing of outcome measurement",
                "sec_num": null
            },
            {
                "text": "We analysed and extracted all outcomes at short-, intermediateand long-term follow-up.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Method and timing of outcome measurement",
                "sec_num": null
            },
            {
                "text": "\u2022 Short-term: from 4 weeks to less than 12 weeks \u2022 Intermediate-term: from 12 weeks to less than 24 weeks \u2022 Long-term: 24 weeks or more If a study reported outcomes at multiple time points within the same period (as listed above), we used the last reported measurement.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Method and timing of outcome measurement",
                "sec_num": null
            },
            {
                "text": "We included eligible studies regardless of whether they reported an outcome of interest in this review.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Method and timing of outcome measurement",
                "sec_num": null
            },
            {
                "text": "We identified studies from searches of the following databases and trial registries: We searched all sources from inception, with no restriction on language of publication.The database search strategies are listed in Appendix 2. The Cochrane Airways Information Specialist developed the search strategy in collaboration with the review authors.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Electronic searches",
                "sec_num": null
            },
            {
                "text": "We checked the reference lists of all primary studies included and of review articles (that were found during the selection process) for additional references.We searched relevant manufacturers' websites for study information.We also searched specific conference proceedings for the British Association of Urological Surgeons (BAUS); European Association of Urology (EAU); and American Urological Association (AUA), searched 14 June 2021.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Searching other resources",
                "sec_num": null
            },
            {
                "text": "We searched for errata or retractions from included studies published in full text on PubMed on 14 June 2021.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Searching other resources",
                "sec_num": null
            },
            {
                "text": "Two review authors (FTB, LESF, or MPS) independently screened the titles and abstracts of the search results, and coded them as 'retrieve' (eligible or potentially eligible, or unclear), or 'do not retrieve'.We retrieved the full-text study reports of all potentially eligible studies, and two review authors (FTB, LESF or MPS) independently screened them for inclusion, recording the reasons for exclusion of ineligible studies.We resolved any disagreement through discussion, or if was required, we consulted a third review author (RR).We identified and excluded duplicates, and collated multiple reports of the same study, so that each study, rather than each report, was the unit of interest in the review.We recorded the selection process in su icient detail to complete a PRISMA flow diagram and 'Characteristics of excluded studies' table (Moher 2009 ; Figure 1 ).",
                "cite_spans": [
                    {
                        "start": 846,
                        "end": 857,
                        "text": "(Moher 2009",
                        "ref_id": null
                    }
                ],
                "ref_spans": [
                    {
                        "start": 867,
                        "end": 868,
                        "text": "1",
                        "ref_id": null
                    }
                ],
                "eq_spans": [],
                "section": "Selection of studies",
                "sec_num": null
            },
            {
                "text": "We used a standard data collection form for study characteristics and outcome data, which had been piloted on at least one study in the review, and contained the following characteristics from included studies.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Data extraction and management",
                "sec_num": null
            },
            {
                "text": "\u2022 Methods: study design, total duration of study, details of any 'run-in' period, number of study centres and location, study setting, withdrawals, and date of study If necessary (data were lacking), we contacted the authors of included trials by email to request further information.We presented the results of these communications in Appendix 3.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Data extraction and management",
                "sec_num": null
            },
            {
                "text": "If there were duplicate publications, companion documents, or multiple reports for a single primary study, we gathered all the available data by collating them in a single data extraction form.We inserted all additional publications under the main study identification of the included or excluded trial.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Dealing with duplicate publications",
                "sec_num": null
            },
            {
                "text": "If results of included trials were available in a trial register database, we collated this information in the appropriate data extraction form.If an included trial was marked as complete in a trial register database, but no additional information (results, or reporting, or both) was available, we planned to assign this trial to 'Studies awaiting classification'.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Data from clinical trial registers",
                "sec_num": null
            },
            {
                "text": "Two review authors (FTB, DVP) independently assessed risk of bias for each study using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2020) .We resolved any disagreements by discussion, or by involving another review author (RR).We assessed the risk of bias according to the following domains:",
                "cite_spans": [
                    {
                        "start": 174,
                        "end": 188,
                        "text": "(Higgins 2020)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Assessment of risk of bias in included studies",
                "sec_num": null
            },
            {
                "text": "\u2022 Random sequence generation;",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Assessment of risk of bias in included studies",
                "sec_num": null
            },
            {
                "text": "\u2022 Allocation concealment;",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Assessment of risk of bias in included studies",
                "sec_num": null
            },
            {
                "text": "\u2022 Blinding of participants and personnel;",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Assessment of risk of bias in included studies",
                "sec_num": null
            },
            {
                "text": "\u2022 Blinding of outcome assessment;",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Assessment of risk of bias in included studies",
                "sec_num": null
            },
            {
                "text": "\u2022 Incomplete outcome data;",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Assessment of risk of bias in included studies",
                "sec_num": null
            },
            {
                "text": "\u2022 Selective outcome reporting;",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Assessment of risk of bias in included studies",
                "sec_num": null
            },
            {
                "text": "\u2022 Other bias.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Assessment of risk of bias in included studies",
                "sec_num": null
            },
            {
                "text": "We judged each potential source of bias as high, low, or unclear, and provided a quote from the study report, together with a justification for our judgement in the risk of bias table.We summarised the risk of bias judgements across di erent studies for each of the domains listed.We considered blinding and incomplete outcome data separately for di erent outcomes.Where information on risk of bias was related to unpublished data or correspondence with a trialist, we noted this in the risk of bias tables.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Assessment of risk of bias in included studies",
                "sec_num": null
            },
            {
                "text": "When considering treatment e ects, we took into account the risk of bias for the studies that contributed to that outcome.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Assessment of risk of bias in included studies",
                "sec_num": null
            },
            {
                "text": "We conducted the review according to published protocol (Silva 2018) and justified any deviations from it in the 'Di erences between protocol and review' section of the systematic review.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Assessment of bias in conducting the systematic review",
                "sec_num": null
            },
            {
                "text": "We analysed dichotomous data as risk ratio (RR) when the number of men experiencing a specified outcome, or when healthrelated and sex-related quality of life outcomes were presented as dichotomous data (using a cut-o adopted by the trial authors, and based on the literature).For continuous data (health-related and sex-related quality of life), we used the mean di erence (MD), or standardised mean di erence (SMD, when di erent scales were used for the same outcome across the pooled studies).If data from rating scales were combined in a meta-analysis, we ensured they were entered with a consistent direction of e ect (e.g.lower scores always indicated improvement).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Measures of treatment e ect",
                "sec_num": null
            },
            {
                "text": "We undertook meta-analyses only when this was meaningful; that was, if the treatments, participants, and the underlying clinical question were similar enough for pooling to make sense.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Measures of treatment e ect",
                "sec_num": null
            },
            {
                "text": "We described skewed data narratively (for example, as medians and interquartile ranges for each group).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Measures of treatment e ect",
                "sec_num": null
            },
            {
                "text": "When multiple trial arms were reported in a single study, we included only the relevant arms.When two comparisons (e.g.CPAP regimen A versus placebo, and CPAP regimen B versus placebo) were combined in the same meta-analysis, we either combined the active arms, or halved the control group to avoid double-counting.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Measures of treatment e ect",
                "sec_num": null
            },
            {
                "text": "If adjusted analyses were available (ANOVA or ANCOVA), we used these as a preference in our meta-analyses.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Measures of treatment e ect",
                "sec_num": null
            },
            {
                "text": "In the case of cross-over trials, we planned to use only results from the first treatment phase to avoid any carry-over e ect.For cluster-RCTs, we planned to calculate the design e ect using the intra cluster correlation coe icient (ICC).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Measures of treatment e ect",
                "sec_num": null
            },
            {
                "text": "We used intention-to-treat (ITT) or 'full analysis set' analyses when they were reported (i.e. when data were imputed for participants who were randomly assigned but did not complete the study), instead of complete or 'per protocol' analyses.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Measures of treatment e ect",
                "sec_num": null
            },
            {
                "text": "For dichotomous outcomes, we used participants, rather than events, as the unit of analysis (i.e.number of participants presenting with at least one serious adverse events, rather than",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Unit of analysis issues",
                "sec_num": null
            },
            {
                "text": "Trusted evidence.Informed decisions.Better health.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "Cochrane Database of Systematic Reviews the number of serious adverse events).However, if rate ratios were reported in a study, we analysed them on this basis.We only planned to meta-analyse data from cluster-RCTs if the available data were adjusted (or could be adjusted), to account for the clustering.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "We contacted investigators or study sponsors to verify key study characteristics and obtain missing numerical outcome data, when possible (e.g. when a study was identified as an abstract only).When this was not possible, and the missing data were thought to introduce serious bias, we took this into consideration in the GRADE rating for a ected outcomes, and in our judgement of risk of bias.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Dealing with missing data",
                "sec_num": null
            },
            {
                "text": "We investigated clinical, methodological, and statistical heterogeneity among included trials.We did not pool e ect estimates in a meta-analysis if we identified substantial clinical or methodological heterogeneity among included studies.We identified statistical heterogeneity by visual inspection of the forest plots, and by using a standard Chi test (significance level of 0.1).We quantified this heterogeneity by using the I statistic; an I statistic of 50% or more indicated substantial heterogeneity (Higgins 2020 ).When we found substantial heterogeneity, we attempted to determine possible reasons for it by individually exploring the trials included in the meta-analysis, and by performing subgroup analyses.",
                "cite_spans": [
                    {
                        "start": 506,
                        "end": 519,
                        "text": "(Higgins 2020",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Assessment of heterogeneity",
                "sec_num": null
            },
            {
                "text": "We planned to create funnel plots to explore possible publication biases for meta-analysis with 10 or more studies.We did not investigate publication bias because of the low number of RCTs included in the meta-analysis.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Assessment of reporting biases",
                "sec_num": null
            },
            {
                "text": "We used a random-e ects model for meta-analysis, and performed a sensitivity analysis with a fixed-e ect model.When we considered meta-analysis to be inappropriate, we provided a narrative description of the study results.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Data synthesis",
                "sec_num": null
            },
            {
                "text": "We planned the following subgroup analyses for the primary outcomes.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Subgroup analysis and investigation of heterogeneity",
                "sec_num": null
            },
            {
                "text": "\u2022 Partial versus complete adherence.We defined complete adherence as a mean of four or more hours of non-invasive positive airway pressure device use per night, for at least one month, at any pressure level and, with any brand (Antic 2011; Sawyer 2011; Weaver 2007; Zimmerman 2006).We expected better results for men with complete adherence.\u2022 Obese versus non-obese participants.We defined obesity as body mass index (BMI) greater than 30.We expected better results for non-obese participants.\u2022 Older participants (60 years or older) versus younger participants (younger than 60 years).We expected better results for younger participants.\u2022 Di erences between CPAP, BIPAP, VPAP, or similar devices.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Subgroup analysis and investigation of heterogeneity",
                "sec_num": null
            },
            {
                "text": "We planned to use the formal test for subgroup interactions available in Review Manager 5 (RevMan Web 2020).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Subgroup analysis and investigation of heterogeneity",
                "sec_num": null
            },
            {
                "text": "We did not conduct any subgroup analyses because of the scarcity of studies included in each meta-analysis.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Subgroup analysis and investigation of heterogeneity",
                "sec_num": null
            },
            {
                "text": "We planned to carry out sensitivity analyses by removing trials with high risk of bias (those classified as having high risk of bias in at least one of the following domains: random sequence generation, allocation concealment, and blinding) from the primary outcome analyses.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Sensitivity analysis",
                "sec_num": null
            },
            {
                "text": "We planned to test the robustness of results by repeating the analyses using a fixed-e ect model.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Sensitivity analysis",
                "sec_num": null
            },
            {
                "text": "We created a summary of findings table, using all primary and secondary outcomes.We used the five GRADE considerations (risk of bias, consistency of e ect, imprecision, indirectness, and publication bias) to assess the certainty of the body of evidence as it related to the studies that contributed data for each prespecified outcome.We used the methods and recommendations described in Section 8.5 and Chapter 12 of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2020) , and GRADEpro GDT so ware (GRADEpro GDT).We used footnotes to justify all decisions to downgrade our assessments of the certainty of evidence, and we made comments to aid the reader's understanding of the review where necessary.",
                "cite_spans": [
                    {
                        "start": 479,
                        "end": 493,
                        "text": "(Higgins 2020)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Summary of findings and assessment of the certainty of the evidence",
                "sec_num": null
            },
            {
                "text": "Two review authors (FTB, RR) independently rated the certainty of evidence for each outcome as high, moderate, low, or very low; discrepancies were resolved by a third author (LESF).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Summary of findings and assessment of the certainty of the evidence",
                "sec_num": null
            },
            {
                "text": "We summarised the characteristics of participants, interventions, and outcomes of the included studies in the Characteristics of included studies table.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Description of studies",
                "sec_num": null
            },
            {
                "text": "The search strategy retrieved 529 records (up to 14 June 2021).A er removing duplicates, two review authors (FTB, LESF, or MPS) independently screened the titles and abstracts of 365 records, excluded 345 records, and selected 20 for full-text assessment.We excluded four (Hoekema 2007; Karkoulias 2006; Perimenis 2007a; Taskin 2010) .We included six studies, reported in 16 records (Li 2004; Melehan 2018; Pascual 2018; Pastore 2014; Perimenis 2004; Perimenis 2007) .Figure 1 presents the process of study selection.",
                "cite_spans": [
                    {
                        "start": 272,
                        "end": 286,
                        "text": "(Hoekema 2007;",
                        "ref_id": null
                    },
                    {
                        "start": 287,
                        "end": 303,
                        "text": "Karkoulias 2006;",
                        "ref_id": null
                    },
                    {
                        "start": 304,
                        "end": 320,
                        "text": "Perimenis 2007a;",
                        "ref_id": null
                    },
                    {
                        "start": 321,
                        "end": 333,
                        "text": "Taskin 2010)",
                        "ref_id": null
                    },
                    {
                        "start": 383,
                        "end": 392,
                        "text": "(Li 2004;",
                        "ref_id": null
                    },
                    {
                        "start": 393,
                        "end": 406,
                        "text": "Melehan 2018;",
                        "ref_id": null
                    },
                    {
                        "start": 407,
                        "end": 420,
                        "text": "Pascual 2018;",
                        "ref_id": null
                    },
                    {
                        "start": 421,
                        "end": 434,
                        "text": "Pastore 2014;",
                        "ref_id": null
                    },
                    {
                        "start": 435,
                        "end": 450,
                        "text": "Perimenis 2004;",
                        "ref_id": null
                    },
                    {
                        "start": 451,
                        "end": 466,
                        "text": "Perimenis 2007)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [
                    {
                        "start": 475,
                        "end": 476,
                        "text": "1",
                        "ref_id": null
                    }
                ],
                "eq_spans": [],
                "section": "Results of the search",
                "sec_num": null
            },
            {
                "text": "The included trials were published between 2004 and 2018.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Date of publication",
                "sec_num": null
            },
            {
                "text": "Five studies were single-centre randomised clinical trials (RCT) with a parallel-group design.They were conducted in China (Li 2004 ), Spain (Pastore 2014), Italy ( Pascual 2018), and Greece (Perimenis 2004; Perimenis 2007).One RCT was a multicentric two by two factorial parallel-group trial, conducted in two Australian centres (Sydney and Clayton (Melehan 2018)).",
                "cite_spans": [
                    {
                        "start": 123,
                        "end": 131,
                        "text": "(Li 2004",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Design and setting",
                "sec_num": null
            },
            {
                "text": "Overall, 315 participants with obstructive sleep apnoea syndrome (OSAS) and erectile dysfunction (ED) were randomised of whom 297 (94%) had their data analysed.The sample size of RCTs ranged from 27 (Li 2004 ) to 82 (Pastore 2014).",
                "cite_spans": [
                    {
                        "start": 199,
                        "end": 207,
                        "text": "(Li 2004",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Sample size",
                "sec_num": null
            },
            {
                "text": "The mean age of participants ranged from 39.8 years (Li 2004 ), to 56.1 years (Perimenis 2004).The participants presented with mild OSAS in two RCTs (Perimenis 2004; Perimenis 2007) , moderate to severe in three RCTs (Li 2004; Melehan 2018; Pascual 2018) , and severe in one RCT (Pastore 2014).",
                "cite_spans": [
                    {
                        "start": 52,
                        "end": 60,
                        "text": "(Li 2004",
                        "ref_id": null
                    },
                    {
                        "start": 149,
                        "end": 165,
                        "text": "(Perimenis 2004;",
                        "ref_id": null
                    },
                    {
                        "start": 166,
                        "end": 181,
                        "text": "Perimenis 2007)",
                        "ref_id": null
                    },
                    {
                        "start": 217,
                        "end": 226,
                        "text": "(Li 2004;",
                        "ref_id": null
                    },
                    {
                        "start": 227,
                        "end": 240,
                        "text": "Melehan 2018;",
                        "ref_id": null
                    },
                    {
                        "start": 241,
                        "end": 254,
                        "text": "Pascual 2018)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Participants",
                "sec_num": null
            },
            {
                "text": "The RCTs compared CPAP with no CPAP (Li 2004 ",
                "cite_spans": [
                    {
                        "start": 36,
                        "end": 44,
                        "text": "(Li 2004",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Interventions and controls",
                "sec_num": null
            },
            {
                "text": "The RCTs addressed the following outcomes of interest for this review:",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Outcomes",
                "sec_num": null
            },
            {
                "text": "\u2022",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Outcomes",
                "sec_num": null
            },
            {
                "text": "We did not identify any ongoing studies.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Ongoing studies",
                "sec_num": null
            },
            {
                "text": "We excluded four studies because they used the wrong comparisons (Hoekema 2007; Karkoulias 2006; Perimenis 2007a; Taskin 2010); see Characteristics of excluded studies for details.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Excluded studies",
                "sec_num": null
            },
            {
                "text": "We assessed the risk of bias in the included RCTs with the Cochrane ROB 1 tool, and classified the domains as low risk, high risk, and unclear risk of bias (Higgins 2020) .See Figure 2 ",
                "cite_spans": [
                    {
                        "start": 156,
                        "end": 170,
                        "text": "(Higgins 2020)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [
                    {
                        "start": 183,
                        "end": 184,
                        "text": "2",
                        "ref_id": null
                    }
                ],
                "eq_spans": [],
                "section": "Risk of bias in included studies",
                "sec_num": null
            },
            {
                "text": "Five RCTs reported that participants, personnel, and investigators were not blinded; therefore they were at high risk (Li 2004; Pascual 2018; Pastore 2014; Perimenis 2004; Perimenis 2007) .Melehan 2018 reported that participants and study investigators were blinded to treatment allocation (and adherence) for the duration of the trial, and we judged it at low risk.",
                "cite_spans": [
                    {
                        "start": 118,
                        "end": 127,
                        "text": "(Li 2004;",
                        "ref_id": null
                    },
                    {
                        "start": 128,
                        "end": 141,
                        "text": "Pascual 2018;",
                        "ref_id": null
                    },
                    {
                        "start": 142,
                        "end": 155,
                        "text": "Pastore 2014;",
                        "ref_id": null
                    },
                    {
                        "start": 156,
                        "end": 171,
                        "text": "Perimenis 2004;",
                        "ref_id": null
                    },
                    {
                        "start": 172,
                        "end": 187,
                        "text": "Perimenis 2007)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Blinding",
                "sec_num": null
            },
            {
                "text": "We assessed five RCTs at low risk of bias; four reported no losses (Li 2004; Pastore 2014; Perimenis 2004; Perimenis 2007) , while Melehan 2018 reported less than 10% loss.We judged Pascual 2018 at high risk of bias because of significant loss (18/75).",
                "cite_spans": [
                    {
                        "start": 67,
                        "end": 76,
                        "text": "(Li 2004;",
                        "ref_id": null
                    },
                    {
                        "start": 77,
                        "end": 90,
                        "text": "Pastore 2014;",
                        "ref_id": null
                    },
                    {
                        "start": 91,
                        "end": 106,
                        "text": "Perimenis 2004;",
                        "ref_id": null
                    },
                    {
                        "start": 107,
                        "end": 122,
                        "text": "Perimenis 2007)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Incomplete outcome data",
                "sec_num": null
            },
            {
                "text": "Three RCTs did not provide enough information to assess reporting bias (unclear risk (Li 2004 ; Pastore 2014; Perimenis 2007)).We judged three RCTs at high risk of reporting bias: Melehan 2018 did not report all pre-planned time points for the primary outcome (four and eight weeks), not even in the supplementary material, and provided the data combined in pairs of interventions rather than individually, for the four intervention groups; Pascual 2018 presented a protocol registration date later than the inclusion of the first participant; and Perimenis 2004 did not report the number of adverse events.",
                "cite_spans": [
                    {
                        "start": 85,
                        "end": 93,
                        "text": "(Li 2004",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Selective reporting",
                "sec_num": null
            },
            {
                "text": "We found no other sources of potential bias, and judged the RCTs as having a low risk of bias for this domain.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Other potential sources of bias",
                "sec_num": null
            },
            {
                "text": "See: Summary of findings 1 Continuous positive airway pressure (CPAP) compared to no CPAP for improving erectile dysfunction in men with obstructive sleep apnoea; Summary of findings 2 Continuous positive airway pressure (CPAP) compared to sham CPAP for improving erectile dysfunction in men with obstructive sleep apnoea; Summary of findings 3 Continuous positive airway pressure (CPAP) compared to phosphodiesterase type 5 inhibitors for improving erectile dysfunction in men with obstructive sleep apnoea",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "E ects of interventions",
                "sec_num": null
            },
            {
                "text": "Considering the heterogeneity among included RCTs and the available data, we only conducted quantitative syntheses for the outcomes erectile dysfunction and sex-related quality of life, under the comparison of CPAP versus phosphodiesterase type 5 inhibitors.For all other outcomes and comparisons, we only completed qualitative syntheses.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "E ects of interventions",
                "sec_num": null
            },
            {
                "text": "In Melehan 2018, authors did not report the results for each of the four intervention groups, but provided the results for two comparisons, based on the two-by-two factorial groups:",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "E ects of interventions",
                "sec_num": null
            },
            {
                "text": "\u2022 CPAP (combined with placebo or vardenafil) versus sham (combined with placebo or vardenafil);",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "E ects of interventions",
                "sec_num": null
            },
            {
                "text": "Trusted evidence.Informed decisions.Better health.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "\u2022 Vardenalfil (combined with CPAP or sham CPAP) versus placebo (combined with CPAP or sham CPAP).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cochrane Database of Systematic Reviews",
                "sec_num": null
            },
            {
                "text": "For this reason, we were unable to include the results from this RCT in our analyses.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cochrane Database of Systematic Reviews",
                "sec_num": null
            },
            {
                "text": "Two RCTs assessed this comparison (Li 2004; Pascual 2018) .",
                "cite_spans": [
                    {
                        "start": 34,
                        "end": 43,
                        "text": "(Li 2004;",
                        "ref_id": null
                    },
                    {
                        "start": 44,
                        "end": 57,
                        "text": "Pascual 2018)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Comparison 1: CPAP versus no CPAP",
                "sec_num": null
            },
            {
                "text": "Neither of the RCTs provided data on remission rate of ED, but both provided mean ED scores.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Remission of ED",
                "sec_num": null
            },
            {
                "text": "One RCT assessed this outcome and the authors reported no serious adverse event a er four weeks (Li 2004 ).",
                "cite_spans": [
                    {
                        "start": 96,
                        "end": 104,
                        "text": "(Li 2004",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Serious adverse events",
                "sec_num": null
            },
            {
                "text": "One RCT assessed this outcome and used the Self-Esteem and Relationship test (SEAR) (MD 1.00; 95% CI -8.09 to 10.09; one study; 57 participants; very low-certainty evidence, downgraded due to methodological limitations and imprecision; Analysis 1.2) (Pascual 2018).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Sex-related quality of life",
                "sec_num": null
            },
            {
                "text": "No RCTs assessed this outcome.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Health-related quality of life",
                "sec_num": null
            },
            {
                "text": "No RCTs assessed this outcome.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Minor adverse events",
                "sec_num": null
            },
            {
                "text": "One RCT assessed this comparison, but we were unable to extract data for the outcomes for this comparison (Melehan 2018).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Comparison 2: CPAP versus sham CPAP",
                "sec_num": null
            },
            {
                "text": "Melehan 2018 assessed this outcome, but we were unable to extract separate data.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Remission of ED",
                "sec_num": null
            },
            {
                "text": "Melehan 2018 did not assess this outcome.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Serious adverse events",
                "sec_num": null
            },
            {
                "text": "Melehan 2018 assessed this outcome with the EDITS tool, but we were unable to extract separate data.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Sex-related quality of life",
                "sec_num": null
            },
            {
                "text": "Melehan 2018 assessed this outcome with the SF-36, but we were unable to extract separate data.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Health-related quality of life",
                "sec_num": null
            },
            {
                "text": "Melehan 2018 did not assess this outcome.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Minor adverse events",
                "sec_num": null
            },
            {
                "text": "None of RCTs provided data on remission rate of ED, but rather provided mean scores.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Remission of ED",
                "sec_num": null
            },
            {
                "text": "Two RCTs measured this outcome (Perimenis 2004; Perimenis 2007) and reported that no adverse event was significant and no participant required any specific treatment, nor did they withdraw from the study (RR not estimable; participants = 70; studies = 2; very low-certainty evidence, downgraded due to methodological limitations and imprecision).Melehan 2018 measured this outcome with the EDITS, but did not report the results; Perimenis 2004 did not use a validated tool to measure this outcome.",
                "cite_spans": [
                    {
                        "start": 31,
                        "end": 47,
                        "text": "(Perimenis 2004;",
                        "ref_id": null
                    },
                    {
                        "start": 48,
                        "end": 63,
                        "text": "Perimenis 2007)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Serious adverse events",
                "sec_num": null
            },
            {
                "text": "One RCT measured this outcome, using the SF-36, but did not report the results (Melehan 2018). 3) .The confidence interval was wide, and neither an important increase nor reduction in the risk of minor adverse events can be ruled out with the use of CPAP.",
                "cite_spans": [
                    {
                        "start": 95,
                        "end": 97,
                        "text": "3)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Health-related quality of life",
                "sec_num": null
            },
            {
                "text": "This systematic review included six randomised controlled trials (RCT) with a total of 297 participants with obstructive sleep apnoea syndrome (OSAS) and erectile dysfunction (ED).We are uncertain about the e ectiveness and acceptability of continuous positive airway pressure (CPAP) for erectile dysfunction when compared to no intervention, sham CPAP, or phosphodiesterase type 5 inhibitors for this condition.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "D I S C U S S I O N",
                "sec_num": null
            },
            {
                "text": "The main findings of this review showed the following:",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Summary of main results",
                "sec_num": null
            },
            {
                "text": "\u2022 There is uncertainty about the e ects of CPAP on ED at 4 and 12 weeks (very low-certainty evidence); \u2022 There is uncertainty about the e ects of CPAP on sex-related quality of life a er 12 weeks (very low-certainty evidence); \u2022 No other outcomes of interest were reported or assessed.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "CPAP versus no CPAP",
                "sec_num": null
            },
            {
                "text": "Trusted evidence.Informed decisions.Better health.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "The factorial design and reporting of the trial that examined this comparison meant that we were unable to extract outcomes matching our prespecified comparisons.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "CPAP versus sham CPAP",
                "sec_num": null
            },
            {
                "text": "\u2022 Sildenafil may slightly improve ED over CPAP at 12 weeks (lowcertainty evidence); \u2022 There is uncertainty about the e ects of CPAP on sex-related quality of life at 12 weeks (very low-certainty evidence); \u2022 There is uncertainty about the e ect of CPAP on serious and minor adverse events (very low-certainty evidence).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "CPAP versus phosphodiesterase type 5 (PDE5) inhibitors",
                "sec_num": null
            },
            {
                "text": "The included RCTs exclusively addressed CPAP, so we are unaware of the e ects of bilevel positive airway pressure (BiPAP), variable positive airway pressure (VPAP), or similar devices for men with OSAS and ED.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Overall completeness and applicability of evidence",
                "sec_num": null
            },
            {
                "text": "It is important to highlight that even if the e ect suggested by the available evidence is true, this estimate refers to intermediate-term e ects, and may be not applicable for the long term, when for example, it is reasonable to expect additional adverse events with drugs and lower adherence to CPAP use.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Overall completeness and applicability of evidence",
                "sec_num": null
            },
            {
                "text": "In addition, adherence to CPAP use was not assessed or reported by any of the included RCTs, and we are not sure if the recommendations were followed by participants of RCTs (mean of four or more hours of CPAP use per night, for at least four weeks, at any pressure level, and with any brand of machine).Finally, none of included RCTs provided data for remission rate of ED, but rather, they provided mean scores of ED.Other relevant outcomes were not considered or were poorly reported by the RCTs, such as sexrelated quality of life, and health-related quality of life.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Overall completeness and applicability of evidence",
                "sec_num": null
            },
            {
                "text": "For this comparison no data was found for minor adverse events and heath-related quality of life.This evidence is derived from RCT including participants with mean age from 39.8 to 54.8 and moderate to severe OSAS.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "CPAP versus no CPAP",
                "sec_num": null
            },
            {
                "text": "One RCT (Melehan 2018 ) considered this comparison, but the factorial design and reporting of this trial meant that we were unable to extract outcomes matching our pre-specified comparisons.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "CPAP versus sham CPAP",
                "sec_num": null
            },
            {
                "text": "For this comparison, none of included RCTs reported health-related quality of life.For ED, there is low evidence certainty that sildenafil may slightly improve ED scores, and for all other outcomes (sexrelated quality of life, serious and minor adverse events) the evidence available is so uncertain that no e ect estimate is known.We also noted that the two RCTs, used a high dose of sildenafil (100mg) which, although within the maximum recommended dose (25 mg to 100 mg), is higher than the doses used for most of the participants in clinical practice (25 mg to 50 mg).This evidence is derived from RCT including participants with mean age from 48 to 56 and moderate to severe OSAS.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "CPAP versus sildenafil",
                "sec_num": null
            },
            {
                "text": "One RCT (Melehan 2018 ) considered this comparison, but the factorial design and reporting of this trial meant that we were unable to extract outcomes matching our pre-specified comparisons.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "CPAP versus vardenafil",
                "sec_num": null
            },
            {
                "text": "For all the outcomes, the certainty of the evidence was low to very low, which means that no definitive recommendations can be made from the data available at the moment.We downgraded the certainty of the evidence due to methodological limitation of the RCTs and imprecision (few RCTs, small sample size, low rate of events, wide 95% CI including both a clinical important benefit or harm).See Summary of findings 1; Summary of findings 2; Summary of findings 3 for more details.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Quality of the evidence",
                "sec_num": null
            },
            {
                "text": "Two review authors individually appraised all the studies, and the risk of any biases, other than those detailed in the risk of bias tables, is very unlikely.None of the review authors have any conflicts of interest to declare.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Potential biases in the review process",
                "sec_num": null
            },
            {
                "text": "We followed the recommendations of the Cochrane Handbook for Systematic Reviews of Interventions in all steps of this review to minimise bias (Higgins 2020) .The search strategy was broad and sensitive, and it is likely that it identified all randomised controlled trials.This can be considered one of the strengths of this review.",
                "cite_spans": [
                    {
                        "start": 142,
                        "end": 156,
                        "text": "(Higgins 2020)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Potential biases in the review process",
                "sec_num": null
            },
            {
                "text": "Limitations of the review include the lack of some outcome data in the included studies; remission of erectile dysfunction could not be assessed due to lack of reporting of the number of participants achieving remission; the authors reported only the average with standard deviation.The available data were su icient for metaanalysis for only two outcomes (erectile dysfunction and sexrelated quality of life), from two RCTs.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Potential biases in the review process",
                "sec_num": null
            },
            {
                "text": "We did not identify any other systematic review that assessed the same clinical question addressed here.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Agreements and disagreements with other studies or reviews",
                "sec_num": null
            },
            {
                "text": "We identified one similar systematic review that considered the comparison CPAP versus sildenafil (Li 2019) .This review included 26 RCTs and observational studies.The literature search was restricted to three data sources, and sought reports published to 1 December 2018.As in our review, the results suggested that CPAP was less e ective than PDE5 inhibitors in the treating ED in men with OSAS, and the certainty of the evidence was low or very low.",
                "cite_spans": [
                    {
                        "start": 98,
                        "end": 107,
                        "text": "(Li 2019)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Agreements and disagreements with other studies or reviews",
                "sec_num": null
            },
            {
                "text": "The current evidence does not support or refute the routine use of CPAP as a valid therapeutic option.We are uncertain about the e ectiveness and acceptability of CPAP for the treatment of erectile dysfunction in men with OSAP, when compared with no CPAP.When CPAP is compared with sildenafil, we found sildenafil may slightly improve erectile function at 12 weeks.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Implications for practice",
                "sec_num": null
            },
            {
                "text": "Blinding of participants and personnel (performance bias) Remission of ED High risk Quote: \"The control group was not treated with a ventilator, but slept in the observation room in the same condition as the treatment group.\"",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cochrane Database of Systematic Reviews",
                "sec_num": null
            },
            {
                "text": "Comments: the treatment group (CPAP) was compared with no treatment Blinding of participants and personnel (performance bias) Serious adverse events",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cochrane Database of Systematic Reviews",
                "sec_num": null
            },
            {
                "text": "High risk Quote: \"The control group was not treated with a ventilator, but slept in the observation room in the same condition as the treatment group.\"",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cochrane Database of Systematic Reviews",
                "sec_num": null
            },
            {
                "text": "Comments: the treatment group (CPAP) was compared with no treatment Blinding of outcome assessment (detection bias) Remission of ED High risk Quote: \"The control group was not treated with a ventilator, but slept in the observation room in the same condition as the treatment group.\"",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cochrane Database of Systematic Reviews",
                "sec_num": null
            },
            {
                "text": "Comments: the treatment group (CPAP) was compared with no treatment Blinding of outcome assessment (detection bias) Serious adverse events",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cochrane Database of Systematic Reviews",
                "sec_num": null
            },
            {
                "text": "High risk Quote: \"The control group was not treated with a ventilator, but slept in the observation room in the same condition as the treatment group.\"",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cochrane Database of Systematic Reviews",
                "sec_num": null
            },
            {
                "text": "Comments: the treatment group (CPAP) was compared with no treatment",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cochrane Database of Systematic Reviews",
                "sec_num": null
            },
            {
                "text": "Low risk There were no losses.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Incomplete outcome data (attrition bias) Remission of ED",
                "sec_num": null
            },
            {
                "text": "Low risk There were no losses.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Incomplete outcome data (attrition bias) Serious adverse events",
                "sec_num": null
            },
            {
                "text": "Selective reporting (reporting bias)",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Incomplete outcome data (attrition bias) Serious adverse events",
                "sec_num": null
            },
            {
                "text": "We did not find a protocol.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Unclear risk",
                "sec_num": null
            },
            {
                "text": "We did not find any other sources of bias.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Other bias Low risk",
                "sec_num": null
            },
            {
                "text": "Methods Aim of study: to assess the effects of CPAP and vardenafil on ED Study design: 2 x 2 factorial parallel RCT Study grouping: 2 x 2 factorial parallel groups, 1:1:1:1 rate: CPAP + vardenafil, CPAP + placebo, sham CPAP + vardenafil, sham CPAP + placebo.However, the results were reported for two comparisons and based on the 2 x 2 factorial groups.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Study characteristics",
                "sec_num": null
            },
            {
                "text": "\u2022 CPAP (combined with placebo or vardenafil) versus sham CPAP (combined with placebo or vardenafil) Exclusion criteria: irreversible erectile dysfunction, concurrent treatment with nitrates or nitric oxide donors, treatment of ED within the last month, severe renal or hepatic impairment, uncontrolled diabetes or hypertension, current smoker, night shi worker, unable to read the information sheet due to language barrier, any chronic medical condition that may limit participation; men who were unwilling to use CPAP or whose condition required immediate treatment due to severity or occupation Withdrawals and exclusions: six men withdrew from the study after randomisation Mean age \u00b1 SD: not provided by intervention group, but only by the following 2 x 2 factorial groups:",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Study characteristics",
                "sec_num": null
            },
            {
                "text": "\u2022 CPAP (combined with both placebo or vardenafil): 55.7 \u00b1 7.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Study characteristics",
                "sec_num": null
            },
            {
                "text": "Secondary outcomes:",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cochrane Database of Systematic Reviews",
                "sec_num": null
            },
            {
                "text": "\u2022 Sleep-related erection frequency Contact with authors: e-mail sent to main author 3 September 2020.Reply received in 3 September 2020; the author explained that due to ethic reasons, the additional data could not be shared.Baseline imbalances: baseline comparison between study arms revealed no significant differences except for AHI, although no statistically significant differences were found in the proportion of men with severe (AHI > 30 events-1) OSAS -6.60 [-8.48 , -4.72] -3.60 [-6.22 , -0.98] -3.50 [-6.42 , -0. ",
                "cite_spans": [
                    {
                        "start": 460,
                        "end": 522,
                        "text": "-6.60 [-8.48 , -4.72] -3.60 [-6.22 , -0.98] -3.50 [-6.42 , -0.",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cochrane Database of Systematic Reviews",
                "sec_num": null
            },
            {
                "text": "Non-invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea (Review) Copyright \u00a9 2023 The Cochrane Collaboration.Published by John Wiley & Sons, Ltd.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "",
                "sec_num": null
            }
        ],
        "back_matter": [
            {
                "text": "Figure 2. Risk of bias summary: review authors' judgements about each risk of bias item for each included study Random sequence generation (selection bias) Allocation concealment (selection bias) Blinding of participants and personnel (performance bias): Remission of ED Blinding of participants and personnel (performance bias): Serious adverse events Blinding of participants and personnel (performance bias): Sex-related quality of life Blinding of participants and personnel (performance bias): Health-related quality of life Blinding of participants and personnel (performance bias): Minor adverse events Blinding of outcome assessment (detection bias): Remission of ED Blinding of outcome assessment (detection bias): Serious adverse events Blinding of outcome assessment (detection bias): Sex-related quality of life Blinding of outcome assessment (detection bias): Health-related quality of life Blinding of outcome assessment (detection bias): Minor adverse events Incomplete outcome data (attrition bias): Remission of ED Incomplete outcome data (attrition bias): Serious adverse events Incomplete outcome data (attrition bias): Sex-related quality of life Incomplete outcome data (attrition bias): Health-related quality of life",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "funding",
                "sec_num": null
            },
            {
                "text": "Trusted evidence.Informed decisions.Better health.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "Future high-quality RCTs are needed to evaluate the use of CPAP for the treatment of ED in men with OSAS.These studies should consider:\u2022 Longer follow-up (six months or more) \u2022 Using sham CPAP or phosphodiesterase type 5 inhibitors doses that are usually prescribed in routine medical practice \u2022 Clinically relevant outcomes, including ED measures, quality of life, and adverse events \u2022 Specific subgroups for which phosphodiesterase type 5 inhibitors should be avoided",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Implications for research",
                "sec_num": null
            },
            {
                "text": "The Background and Methods sections of this review are based on a standard template used by Cochrane Airways.This project was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure funding to Cochrane Airways.The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS, or the Department of Health and Social Care.The authors would like to thank:\u2022 the Cochrane Airways editorial team for their support in the development of the protocol and for providing the templates for the Background and Methods sections \u2022 Liz Stovold, Information Specialist, for her support with search strategies \u2022 Cochrane Rio de Janeiro A iliate team, for their methodological supportThe authors and Cochrane Airways' editorial team are grateful to the following peer reviewers for their time and comments: Mikel Rueda-Etxebarria and Jose-Ramon Rueda (Spain).Protocol available from: clinicaltrials.gov/ct2/show/NCT03086122",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "A C K N O W L E D G E M E N T S",
                "sec_num": null
            },
            {
                "text": "The primary outcome was ED, measured by IIEF-15.However, the authors did not provide the overall score, but the individual score for the five domains that comprised the overall score.Other bias Low risk Quote: \"However, although having a randomisation goal of 126 ED patients, the study was stopped at 75.The main reasons for not reaching the recruitment goal were, first, the lower than expected prevalence of ED coupled with tight inclusion criteria, causing a very slow recruitment pace (a planned 2-year study turned out having a 3.5 years recruitment phase); second, the financial constrains caused by the extended recruitment phase; and third, the need to avoid biases caused by changes in the personnel assessing the patients.'Comments: number of randomised participants was much lower than planned.However in accordance with Cochrane Handbook version 5.2, Chapter 8.15.1.6and Table 8 .5.b, the recommendations for early stopping were removed due to (a) \"simulation evidence suggests that inclusion of trials that stopped early in meta-analysis will not lead to substantial bias\"",
                "cite_spans": [],
                "ref_spans": [
                    {
                        "start": 890,
                        "end": 891,
                        "text": "8",
                        "ref_id": null
                    }
                ],
                "eq_spans": [],
                "section": "Aim",
                "sec_num": null
            },
            {
                "text": "Methods Aim of study: to evaluate and compare the efficacy of sildenafil vs. CPAP in men with ED and severe OSAS, and to evaluate and compare the rates of successful intercourse attempts, IIEF-EF scores, and satisfaction with the treatment regimen for men with ED treated with 100 mg sildenafil vs. nasal CPAP",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Study characteristics",
                "sec_num": null
            },
            {
                "text": "Low risk There were no losses.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Incomplete outcome data (attrition bias) Remission of ED",
                "sec_num": null
            },
            {
                "text": "Low risk There were no losses.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Incomplete outcome data (attrition bias) Serious adverse events",
                "sec_num": null
            },
            {
                "text": "Low risk There were no losses.Selective reporting (reporting bias)",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Incomplete outcome data (attrition bias) Minor adverse events",
                "sec_num": null
            },
            {
                "text": "The authors did not report the number of adverse events.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "High risk",
                "sec_num": null
            },
            {
                "text": "No other source of bias was found.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Other bias Low risk",
                "sec_num": null
            },
            {
                "text": "Methods Aim of study: to assess the efficacy of sildenafil and CPAP in the treatment of concurrent ED with OSAS, and to gauge the level of treatment satisfaction in participants and their partners",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Study characteristics",
                "sec_num": null
            },
            {
                "text": "Blinding of outcome assessment (detection bias) Minor adverse events High risk Comment: no mention of any attempt at blinding, by using placebo or sham CPAP, and the outcome is likely to be influenced by lack of blinding",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cochrane Database of Systematic Reviews",
                "sec_num": null
            },
            {
                "text": "Low risk There were no losses.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Incomplete outcome data (attrition bias) Remission of ED",
                "sec_num": null
            },
            {
                "text": "Low risk There were no losses.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Incomplete outcome data (attrition bias) Serious adverse events",
                "sec_num": null
            },
            {
                "text": "Low risk There were no losses.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Incomplete outcome data (attrition bias) Sex-related quality of life",
                "sec_num": null
            },
            {
                "text": "Low risk There were no losses.Selective reporting (reporting bias)",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Incomplete outcome data (attrition bias) Minor adverse events",
                "sec_num": null
            },
            {
                "text": "No protocol was found.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Unclear risk",
                "sec_num": null
            },
            {
                "text": "The study seems to be free of other sources of bias.Cochrane Database of Systematic Reviews",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Other bias Low risk",
                "sec_num": null
            },
            {
                "text": "Chris Cates (Coordinating Editor) checked the data entry prior to the full write-up of the review;Rebecca Fortescue: edited the review; advised on methodology, interpretation, and content; approved the review prior to publication.Hayley Barnes (Contact Editor): edited the review; advised on methodology, interpretation, and content.Emma Dennett (Managing Editor) coordinated the editorial process; advised on interpretation and content; edited the review.Emma Jackson (Assistant Managing Editor) coordinated the peer review process; edited the references and other sections of the review.Elizabeth Stovold (Information Specialist) designed the search strategy; ran the searches; edited the search methods section.The authors declare that no such funding was received for this systematic review",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Contributions of editorial team",
                "sec_num": null
            },
            {
                "text": "\u2022 All, OtherThe authors declare that no such funding was received for this systematic review",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "External sources",
                "sec_num": null
            },
            {
                "text": "Our pre-established primary outcome was erectile function measured as the percentage of participants who presented with erectile dysfunction remission (IIEF-5 \u2265 17 or IIEF \u2265 19).None of the identified RCTs provided these measures.Instead, they provided the means (SD) of the erectile dysfunction scores.We presented these data throughout the review, but always highlighting it was not exactly our planned measurement for the primary outcome.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "D I F F E R E N C E S B E T W E E N P R O T O C O L A N D R E V I E W",
                "sec_num": null
            }
        ],
        "bib_entries": {
            "BIBREF1": {
                "ref_id": "b1",
                "title": "Molecular signatures of obstructive sleep apnea in adults: a review and perspective",
                "authors": [
                    {
                        "first": "E",
                        "middle": [
                            "S"
                        ],
                        "last": "Arnardottir",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [],
                        "last": "Mackiewicz",
                        "suffix": ""
                    },
                    {
                        "first": "T",
                        "middle": [],
                        "last": "Gislason",
                        "suffix": ""
                    },
                    {
                        "first": "K",
                        "middle": [
                            "L"
                        ],
                        "last": "Te",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [
                            "I"
                        ],
                        "last": "Pack",
                        "suffix": ""
                    }
                ],
                "year": 2009,
                "venue": "Sleep",
                "volume": "32",
                "issue": "4",
                "pages": "447--470",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF3": {
                "ref_id": "b3",
                "title": "Mechanisms of cardiac dysfunction in obstructive sleep apnea",
                "authors": [
                    {
                        "first": "J-P",
                        "middle": [],
                        "last": "Baguet",
                        "suffix": ""
                    },
                    {
                        "first": "G",
                        "middle": [],
                        "last": "Barone-Rochette",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [],
                        "last": "Tamisier",
                        "suffix": ""
                    },
                    {
                        "first": "P",
                        "middle": [],
                        "last": "Levy",
                        "suffix": ""
                    },
                    {
                        "first": "J-L",
                        "middle": [],
                        "last": "P\u00e9pin",
                        "suffix": ""
                    }
                ],
                "year": 2012,
                "venue": "Nature Reviews Cardiology",
                "volume": "9",
                "issue": "12",
                "pages": "679--688",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF5": {
                "ref_id": "b5",
                "title": "Long-term changes of sexual function in men with obstructive sleep apnea a er initiation of continuous positive airway pressure",
                "authors": [
                    {
                        "first": "S",
                        "middle": [],
                        "last": "Budweiser",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [],
                        "last": "Luigart",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [
                            "A"
                        ],
                        "last": "J\u00f6rres",
                        "suffix": ""
                    },
                    {
                        "first": "F",
                        "middle": [],
                        "last": "Kollert",
                        "suffix": ""
                    },
                    {
                        "first": "Y",
                        "middle": [],
                        "last": "Kleemann",
                        "suffix": ""
                    },
                    {
                        "first": "W",
                        "middle": [
                            "F"
                        ],
                        "last": "Wieland",
                        "suffix": ""
                    }
                ],
                "year": 2013,
                "venue": "Journal of Sexual Medicine",
                "volume": "10",
                "issue": "",
                "pages": "524--531",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF7": {
                "ref_id": "b7",
                "title": "Development and validation of the self-esteem and relationship (SEAR) questionnaire in erectile dysfunction",
                "authors": [
                    {
                        "first": "J",
                        "middle": [
                            "C"
                        ],
                        "last": "Cappelleri",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [
                            "E"
                        ],
                        "last": "Althof",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [
                            "L"
                        ],
                        "last": "Siegel",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Shpilsky",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [
                            "S"
                        ],
                        "last": "Bell",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [],
                        "last": "Duttagupta",
                        "suffix": ""
                    }
                ],
                "year": 2004,
                "venue": "International Journal of Impotence Research",
                "volume": "16",
                "issue": "",
                "pages": "30--32",
                "other_ids": {
                    "PMID": [
                        "14963468"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF8": {
                "ref_id": "b8",
                "title": "Clinically meaningful improvement on the self-esteem and relationship questionnaire in men with erectile dysfunction",
                "authors": [
                    {
                        "first": "J",
                        "middle": [
                            "C"
                        ],
                        "last": "Cappelleri",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [
                            "E"
                        ],
                        "last": "Althof",
                        "suffix": ""
                    },
                    {
                        "first": "O'",
                        "middle": [],
                        "last": "Leary",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [
                            "P"
                        ],
                        "last": "Glina",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [],
                        "last": "King",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [],
                        "last": "Stecher",
                        "suffix": ""
                    },
                    {
                        "first": "V",
                        "middle": [
                            "J"
                        ],
                        "last": "",
                        "suffix": ""
                    }
                ],
                "year": 2007,
                "venue": "Quality of Life Research",
                "volume": "16",
                "issue": "",
                "pages": "1203--1210",
                "other_ids": {
                    "DOI": [
                        "10.1007/s11136-007-9232-2"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF9": {
                "ref_id": "b9",
                "title": "Clinically important di erence on the erectile dysfunction inventory of treatment satisfaction questionnaire in patients with erectile dysfunction",
                "authors": [
                    {
                        "first": "J",
                        "middle": [
                            "C"
                        ],
                        "last": "Cappelleri",
                        "suffix": ""
                    },
                    {
                        "first": "L",
                        "middle": [
                            "J"
                        ],
                        "last": "Tseng",
                        "suffix": ""
                    },
                    {
                        "first": "V",
                        "middle": [
                            "J"
                        ],
                        "last": "Stecher",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [
                            "E"
                        ],
                        "last": "Althof",
                        "suffix": ""
                    }
                ],
                "year": 2018,
                "venue": "International Journal of Clinical Practice",
                "volume": "72",
                "issue": "4",
                "pages": "",
                "other_ids": {
                    "DOI": [
                        "10.1111/ijcp.13073"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF11": {
                "ref_id": "b11",
                "title": "Sleep-disordered breathing and heart failure: focus on obstructive sleep apnea and treatment with continuous positive airway pressure",
                "authors": [
                    {
                        "first": "M",
                        "middle": [],
                        "last": "Chowdhury",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [],
                        "last": "Adams",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [
                            "J"
                        ],
                        "last": "Whellan",
                        "suffix": ""
                    }
                ],
                "year": 2010,
                "venue": "Journal of Cardiac Failure",
                "volume": "16",
                "issue": "2",
                "pages": "164--174",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF13": {
                "ref_id": "b13",
                "title": "Sildenafil versus continuous positive airway pressure for erectile dysfunction in men with obstructive sleep apnea: a meta-analysis",
                "authors": [
                    {
                        "first": "X",
                        "middle": [],
                        "last": "Li",
                        "suffix": ""
                    },
                    {
                        "first": "Z",
                        "middle": [],
                        "last": "Dong",
                        "suffix": ""
                    },
                    {
                        "first": "Y",
                        "middle": [],
                        "last": "Wan",
                        "suffix": ""
                    },
                    {
                        "first": "Z",
                        "middle": [],
                        "last": "Wang",
                        "suffix": ""
                    }
                ],
                "year": 2010,
                "venue": "Aging Male",
                "volume": "13",
                "issue": "2",
                "pages": "82--86",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF15": {
                "ref_id": "b15",
                "title": "Impotence. NIH Consensus Development Panel on Impotence",
                "authors": [
                    {
                        "first": "M",
                        "middle": [
                            "J"
                        ],
                        "last": "Droller",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "R"
                        ],
                        "last": "Anderson",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "C"
                        ],
                        "last": "Beck",
                        "suffix": ""
                    },
                    {
                        "first": "W",
                        "middle": [
                            "J"
                        ],
                        "last": "Bremner",
                        "suffix": ""
                    },
                    {
                        "first": "K",
                        "middle": [],
                        "last": "Evans",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [],
                        "last": "Gray",
                        "suffix": ""
                    }
                ],
                "year": 1993,
                "venue": "JAMA",
                "volume": "270",
                "issue": "1",
                "pages": "83--90",
                "other_ids": {
                    "PMID": [
                        "8510302"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF17": {
                "ref_id": "b17",
                "title": "Obstructive sleep apnea and stroke",
                "authors": [
                    {
                        "first": "M",
                        "middle": [
                            "E"
                        ],
                        "last": "Dyken",
                        "suffix": ""
                    },
                    {
                        "first": "K",
                        "middle": [
                            "B"
                        ],
                        "last": "Im",
                        "suffix": ""
                    }
                ],
                "year": 2009,
                "venue": "Chest",
                "volume": "136",
                "issue": "6",
                "pages": "1668--1677",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF19": {
                "ref_id": "b19",
                "title": "Pathophysiology of adult obstructive sleep apnea",
                "authors": [
                    {
                        "first": "D",
                        "middle": [
                            "J"
                        ],
                        "last": "Eckert",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Malhotra",
                        "suffix": ""
                    }
                ],
                "year": 2008,
                "venue": "Proceedings of the American Thoracic Society",
                "volume": "5",
                "issue": "2",
                "pages": "144--153",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF21": {
                "ref_id": "b21",
                "title": "Organic impotence",
                "authors": [
                    {
                        "first": "H",
                        "middle": [
                            "K"
                        ],
                        "last": "Walker",
                        "suffix": ""
                    },
                    {
                        "first": "W",
                        "middle": [
                            "D"
                        ],
                        "last": "Hall",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "W"
                        ],
                        "last": "Hurst",
                        "suffix": ""
                    }
                ],
                "year": 1990,
                "venue": "Clinical Methods: The History, Physical, and Laboratory Examinations",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {
                    "PMID": [
                        "21250140"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF23": {
                "ref_id": "b23",
                "title": "Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults",
                "authors": [
                    {
                        "first": "L",
                        "middle": [
                            "J"
                        ],
                        "last": "Epstein",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [],
                        "last": "Kristo",
                        "suffix": ""
                    },
                    {
                        "first": "P",
                        "middle": [
                            "J"
                        ],
                        "last": "Strollo",
                        "suffix": ""
                    },
                    {
                        "first": "N",
                        "middle": [],
                        "last": "Friedman",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Malhotra",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [
                            "P"
                        ],
                        "last": "Patil",
                        "suffix": ""
                    }
                ],
                "year": 2009,
                "venue": "Journal of Clinical Sleep Medicine",
                "volume": "5",
                "issue": "3",
                "pages": "263--276",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF25": {
                "ref_id": "b25",
                "title": "Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Ageing Study",
                "authors": [
                    {
                        "first": "H",
                        "middle": [
                            "A"
                        ],
                        "last": "Feldman",
                        "suffix": ""
                    },
                    {
                        "first": "I",
                        "middle": [],
                        "last": "Goldstein",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [
                            "G"
                        ],
                        "last": "Hatzichristou",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [
                            "J"
                        ],
                        "last": "Krane",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "B"
                        ],
                        "last": "Mckinlay",
                        "suffix": ""
                    }
                ],
                "year": 1994,
                "venue": "Journal of Urology",
                "volume": "151",
                "issue": "1",
                "pages": "54--61",
                "other_ids": {
                    "PMID": [
                        "8254833"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF27": {
                "ref_id": "b27",
                "title": "Sequential, non-arteritic anterior ischemic optic neuropathy in patients taking sildenafil: a report of ten cases",
                "authors": [
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Galvez-Ruiz",
                        "suffix": ""
                    },
                    {
                        "first": "N",
                        "middle": [],
                        "last": "Arishi",
                        "suffix": ""
                    }
                ],
                "year": 2013,
                "venue": "Saudi Journal of Ophthalmology",
                "volume": "27",
                "issue": "4",
                "pages": "241--246",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF29": {
                "ref_id": "b29",
                "title": "Continuous positive airways pressure for obstructive sleep apnoea in adults",
                "authors": [
                    {
                        "first": "T",
                        "middle": [
                            "L"
                        ],
                        "last": "Giles",
                        "suffix": ""
                    },
                    {
                        "first": "T",
                        "middle": [
                            "J"
                        ],
                        "last": "Lasserson",
                        "suffix": ""
                    },
                    {
                        "first": "B",
                        "middle": [
                            "H"
                        ],
                        "last": "Smith",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [],
                        "last": "White",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [],
                        "last": "Wright",
                        "suffix": ""
                    },
                    {
                        "first": "C",
                        "middle": [
                            "J"
                        ],
                        "last": "Cates",
                        "suffix": ""
                    }
                ],
                "year": 2006,
                "venue": "Cochrane Database of Systematic Reviews",
                "volume": "",
                "issue": "3",
                "pages": "",
                "other_ids": {
                    "DOI": [
                        "10.1002/14651858.CD001106.pub3"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF31": {
                "ref_id": "b31",
                "title": "E icacy and safety of sildenafil by age in men with erectile dysfunction",
                "authors": [
                    {
                        "first": "I",
                        "middle": [],
                        "last": "Goldstein",
                        "suffix": ""
                    },
                    {
                        "first": "L",
                        "middle": [
                            "J"
                        ],
                        "last": "Tseng",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [],
                        "last": "Creanga",
                        "suffix": ""
                    },
                    {
                        "first": "V",
                        "middle": [],
                        "last": "Stecher",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "C"
                        ],
                        "last": "Kaminetsky",
                        "suffix": ""
                    }
                ],
                "year": 2016,
                "venue": "Journal of Sexual Medicine",
                "volume": "13",
                "issue": "",
                "pages": "852--859",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF34": {
                "ref_id": "b34",
                "title": "Obstructive sleep apnoea is associated with future subclinical carotid artery disease thirteen-year follow-up from the Wisconsin sleep cohort",
                "authors": [
                    {
                        "first": "S",
                        "middle": [
                            "I"
                        ],
                        "last": "Gunnarsson",
                        "suffix": ""
                    },
                    {
                        "first": "P",
                        "middle": [
                            "E"
                        ],
                        "last": "Peppard",
                        "suffix": ""
                    },
                    {
                        "first": "C",
                        "middle": [
                            "E"
                        ],
                        "last": "Korcarz",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "H"
                        ],
                        "last": "Barnet",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [
                            "E"
                        ],
                        "last": "Aeschlimann",
                        "suffix": ""
                    },
                    {
                        "first": "E",
                        "middle": [
                            "W"
                        ],
                        "last": "Hagen",
                        "suffix": ""
                    }
                ],
                "year": 2014,
                "venue": "Arteriosclerosis, Thrombosis, and Vascular Biology",
                "volume": "34",
                "issue": "10",
                "pages": "2338--2342",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF36": {
                "ref_id": "b36",
                "title": "Cochrane Handbook for Systematic Reviews of Interventions Version 6.1",
                "authors": [
                    {
                        "first": "J",
                        "middle": [
                            "P"
                        ],
                        "last": "Higgins",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [],
                        "last": "Thomas",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [],
                        "last": "Chandler",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [],
                        "last": "Cumpston",
                        "suffix": ""
                    },
                    {
                        "first": "T",
                        "middle": [],
                        "last": "Li",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [
                            "J"
                        ],
                        "last": "Page",
                        "suffix": ""
                    }
                ],
                "year": 2020,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF38": {
                "ref_id": "b38",
                "title": "Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men",
                "authors": [
                    {
                        "first": "C",
                        "middle": [
                            "A"
                        ],
                        "last": "Holden",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [
                            "I"
                        ],
                        "last": "Mclachlan",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [],
                        "last": "Pitts",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [],
                        "last": "Cumming",
                        "suffix": ""
                    },
                    {
                        "first": "G",
                        "middle": [],
                        "last": "Wittert",
                        "suffix": ""
                    },
                    {
                        "first": "P",
                        "middle": [
                            "A"
                        ],
                        "last": "Agius",
                        "suffix": ""
                    }
                ],
                "year": 2005,
                "venue": "Lancet",
                "volume": "366",
                "issue": "",
                "pages": "218--224",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF40": {
                "ref_id": "b40",
                "title": "To ED or not to ED -is erectile dysfunction in obstructive sleep apnea related to endothelial dysfunction?",
                "authors": [
                    {
                        "first": "C",
                        "middle": [
                            "M"
                        ],
                        "last": "Hoyos",
                        "suffix": ""
                    },
                    {
                        "first": "K",
                        "middle": [
                            "L"
                        ],
                        "last": "Melehan",
                        "suffix": ""
                    },
                    {
                        "first": "C",
                        "middle": [
                            "L"
                        ],
                        "last": "Phillips",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [
                            "R"
                        ],
                        "last": "Grunstein",
                        "suffix": ""
                    },
                    {
                        "first": "P",
                        "middle": [
                            "Y"
                        ],
                        "last": "Liu",
                        "suffix": ""
                    }
                ],
                "year": 2015,
                "venue": "Sleep Medicine Reviews",
                "volume": "20",
                "issue": "",
                "pages": "5--14",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF42": {
                "ref_id": "b42",
                "title": "Low quality of life and depressive symptoms as an independent risk factor for erectile dysfunction in patients with obstructive sleep apnea",
                "authors": [
                    {
                        "first": "Y",
                        "middle": [
                            "J"
                        ],
                        "last": "Jeon",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [
                            "W"
                        ],
                        "last": "Yoon",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [],
                        "last": "Han",
                        "suffix": ""
                    },
                    {
                        "first": "T-B",
                        "middle": [],
                        "last": "Won",
                        "suffix": ""
                    },
                    {
                        "first": "D-Y",
                        "middle": [],
                        "last": "Kim",
                        "suffix": ""
                    },
                    {
                        "first": "H-W",
                        "middle": [],
                        "last": "Shin",
                        "suffix": ""
                    }
                ],
                "year": 2015,
                "venue": "Journal of Sexual Medicine",
                "volume": "12",
                "issue": "11",
                "pages": "2168--2177",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF44": {
                "ref_id": "b44",
                "title": "Screening for obstructive sleep apnea in adults: evidence report and systematic review for the US Preventive Services Task Force",
                "authors": [
                    {
                        "first": "D",
                        "middle": [
                            "E"
                        ],
                        "last": "Jonas",
                        "suffix": ""
                    },
                    {
                        "first": "H",
                        "middle": [
                            "R"
                        ],
                        "last": "Amick",
                        "suffix": ""
                    },
                    {
                        "first": "C",
                        "middle": [],
                        "last": "Feltner",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [
                            "P"
                        ],
                        "last": "Weber",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [],
                        "last": "Arvanitis",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Stine",
                        "suffix": ""
                    }
                ],
                "year": 2017,
                "venue": "JAMA",
                "volume": "317",
                "issue": "4",
                "pages": "415--433",
                "other_ids": {
                    "PMID": [
                        "28118460"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF46": {
                "ref_id": "b46",
                "title": "Adult obstructive sleep apnoea",
                "authors": [
                    {
                        "first": "A",
                        "middle": [
                            "S"
                        ],
                        "last": "Jordan",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [
                            "G"
                        ],
                        "last": "Mcsharry",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Malhotra",
                        "suffix": ""
                    }
                ],
                "year": 2014,
                "venue": "Lancet",
                "volume": "383",
                "issue": "",
                "pages": "736--747",
                "other_ids": {
                    "PMID": [
                        "23910433"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF48": {
                "ref_id": "b48",
                "title": "Treatment of obstructive sleep apnoea as a therapeutic modality for associated erectile dysfunction",
                "authors": [
                    {
                        "first": "A",
                        "middle": [
                            "H"
                        ],
                        "last": "Khafagy",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [
                            "H"
                        ],
                        "last": "Khafagy",
                        "suffix": ""
                    }
                ],
                "year": 2012,
                "venue": "International Journal of Clinical Practice",
                "volume": "66",
                "issue": "12",
                "pages": "1204--1208",
                "other_ids": {
                    "PMID": [
                        "23163500"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF50": {
                "ref_id": "b50",
                "title": "Obstructive sleep apnea and hypertension -an update",
                "authors": [
                    {
                        "first": "T",
                        "middle": [],
                        "last": "Konecny",
                        "suffix": ""
                    },
                    {
                        "first": "T",
                        "middle": [],
                        "last": "Kara",
                        "suffix": ""
                    },
                    {
                        "first": "V",
                        "middle": [
                            "K"
                        ],
                        "last": "Somers",
                        "suffix": ""
                    }
                ],
                "year": 2014,
                "venue": "Hypertension",
                "volume": "63",
                "issue": "2",
                "pages": "203--209",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF52": {
                "ref_id": "b52",
                "title": "The e ect of CPAP and PDE5i on erectile function in men with obstructive sleep apnea and erectile dysfunction: a systematic review and meta-analysis",
                "authors": [
                    {
                        "first": "Z",
                        "middle": [],
                        "last": "Li",
                        "suffix": ""
                    },
                    {
                        "first": "Z",
                        "middle": [],
                        "last": "Fang",
                        "suffix": ""
                    },
                    {
                        "first": "N",
                        "middle": [],
                        "last": "Xing",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [],
                        "last": "Zhu",
                        "suffix": ""
                    },
                    {
                        "first": "Y",
                        "middle": [],
                        "last": "Fan",
                        "suffix": ""
                    }
                ],
                "year": 2002,
                "venue": "Journal of Clinical Endocrinology and Metabolism",
                "volume": "48",
                "issue": "7",
                "pages": "3394--3398",
                "other_ids": {
                    "PMID": [
                        "31715462"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF53": {
                "ref_id": "b53",
                "title": "Erectile dysfunction",
                "authors": [
                    {
                        "first": "Lue ;",
                        "middle": [],
                        "last": "Lue",
                        "suffix": ""
                    },
                    {
                        "first": "T",
                        "middle": [
                            "F"
                        ],
                        "last": "",
                        "suffix": ""
                    }
                ],
                "year": 2000,
                "venue": "New England Journal of Medicine",
                "volume": "342",
                "issue": "",
                "pages": "1802--1813",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF55": {
                "ref_id": "b55",
                "title": "Sleep apnea as an independent risk factor Cochrane Database of Systematic Reviews for all-cause mortality: the Busselton Health Study",
                "authors": [
                    {
                        "first": "N",
                        "middle": [
                            "S"
                        ],
                        "last": "Marshall",
                        "suffix": ""
                    },
                    {
                        "first": "Kkh",
                        "middle": [],
                        "last": "Wong",
                        "suffix": ""
                    },
                    {
                        "first": "P",
                        "middle": [
                            "Y"
                        ],
                        "last": "Liu",
                        "suffix": ""
                    },
                    {
                        "first": "Srj",
                        "middle": [],
                        "last": "Cullen",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [
                            "W"
                        ],
                        "last": "Knuiman",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [
                            "R"
                        ],
                        "last": "Grunstein",
                        "suffix": ""
                    }
                ],
                "year": 2008,
                "venue": "Sleep",
                "volume": "31",
                "issue": "8",
                "pages": "1079--1085",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF57": {
                "ref_id": "b57",
                "title": "Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis",
                "authors": [
                    {
                        "first": "C",
                        "middle": [],
                        "last": "Mcdaid",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [],
                        "last": "Gri In",
                        "suffix": ""
                    },
                    {
                        "first": "H",
                        "middle": [],
                        "last": "Weatherly",
                        "suffix": ""
                    },
                    {
                        "first": "K",
                        "middle": [],
                        "last": "Dure",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [],
                        "last": "Van Der Burgt",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [],
                        "last": "Van Hout",
                        "suffix": ""
                    }
                ],
                "year": 2009,
                "venue": "Health Technology Assessment",
                "volume": "13",
                "issue": "4",
                "pages": "143--274",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF59": {
                "ref_id": "b59",
                "title": "Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement",
                "authors": [
                    {
                        "first": "D",
                        "middle": [],
                        "last": "Moher",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Liberati",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [],
                        "last": "Tetzla",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [],
                        "last": "Altman",
                        "suffix": ""
                    }
                ],
                "year": 2009,
                "venue": "PLoS Medicine",
                "volume": "6",
                "issue": "7",
                "pages": "",
                "other_ids": {
                    "DOI": [
                        "10.1371/journal.pmed.1000097"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF61": {
                "ref_id": "b61",
                "title": "The management of erectile dysfunction",
                "authors": [
                    {
                        "first": "D",
                        "middle": [
                            "K"
                        ],
                        "last": "Montague",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "P"
                        ],
                        "last": "Jarow",
                        "suffix": ""
                    },
                    {
                        "first": "G",
                        "middle": [
                            "A"
                        ],
                        "last": "Broderick",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [
                            "R"
                        ],
                        "last": "Dmochowski",
                        "suffix": ""
                    },
                    {
                        "first": "Jpw",
                        "middle": [],
                        "last": "Heaton",
                        "suffix": ""
                    },
                    {
                        "first": "T",
                        "middle": [
                            "F"
                        ],
                        "last": "Lue",
                        "suffix": ""
                    }
                ],
                "year": 2005,
                "venue": "American Urological Association",
                "volume": "1",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF63": {
                "ref_id": "b63",
                "title": "Erectile dysfunction",
                "authors": [
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Muneer",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [],
                        "last": "Kalsi",
                        "suffix": ""
                    },
                    {
                        "first": "I",
                        "middle": [],
                        "last": "Nazareth",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [],
                        "last": "Arya",
                        "suffix": ""
                    }
                ],
                "year": 2014,
                "venue": "BMJ",
                "volume": "348",
                "issue": "",
                "pages": "",
                "other_ids": {
                    "PMID": [
                        "24468580"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF65": {
                "ref_id": "b65",
                "title": "Impotence. NIH Consensus Statement Online",
                "authors": [
                    {
                        "first": "M",
                        "middle": [
                            "J"
                        ],
                        "last": "Droller",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "R"
                        ],
                        "last": "Anderson",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "C"
                        ],
                        "last": "Beck",
                        "suffix": ""
                    },
                    {
                        "first": "W",
                        "middle": [
                            "J"
                        ],
                        "last": "Bremner",
                        "suffix": ""
                    },
                    {
                        "first": "K",
                        "middle": [],
                        "last": "Evans",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [],
                        "last": "Gray",
                        "suffix": ""
                    }
                ],
                "year": 2021,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF67": {
                "ref_id": "b67",
                "title": "Increased prevalence of sleep-disordered breathing in adults",
                "authors": [
                    {
                        "first": "P",
                        "middle": [
                            "E"
                        ],
                        "last": "Peppard",
                        "suffix": ""
                    },
                    {
                        "first": "T",
                        "middle": [],
                        "last": "Young",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "H"
                        ],
                        "last": "Barnet",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [],
                        "last": "Palta",
                        "suffix": ""
                    },
                    {
                        "first": "E",
                        "middle": [
                            "W"
                        ],
                        "last": "Hagen",
                        "suffix": ""
                    },
                    {
                        "first": "K",
                        "middle": [
                            "M"
                        ],
                        "last": "Hla",
                        "suffix": ""
                    }
                ],
                "year": 2013,
                "venue": "American Journal of Epidemiology",
                "volume": "177",
                "issue": "9",
                "pages": "1006--1014",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF69": {
                "ref_id": "b69",
                "title": "The Sleep Apnea Cardiovascular Endpoints (SAVE) study: implications for health services and sleep research in China and elsewhere",
                "authors": [
                    {
                        "first": "Z",
                        "middle": [
                            "H"
                        ],
                        "last": "Qiu",
                        "suffix": ""
                    },
                    {
                        "first": "Y",
                        "middle": [
                            "M"
                        ],
                        "last": "Luo",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [
                            "D"
                        ],
                        "last": "Mcevoy",
                        "suffix": ""
                    }
                ],
                "year": 2017,
                "venue": "Review Manager Web (RevMan Web)",
                "volume": "9",
                "issue": "8",
                "pages": "2217--2220",
                "other_ids": {
                    "PMID": [
                        "28932508"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF71": {
                "ref_id": "b71",
                "title": "The International Index Of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction",
                "authors": [
                    {
                        "first": "R",
                        "middle": [
                            "C"
                        ],
                        "last": "Rosen",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Riley",
                        "suffix": ""
                    },
                    {
                        "first": "G",
                        "middle": [],
                        "last": "Wagner",
                        "suffix": ""
                    },
                    {
                        "first": "I",
                        "middle": [
                            "H"
                        ],
                        "last": "Osterloh",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [],
                        "last": "Kirkpatrick",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Mishra",
                        "suffix": ""
                    }
                ],
                "year": 1997,
                "venue": "Urology",
                "volume": "49",
                "issue": "6",
                "pages": "822--830",
                "other_ids": {
                    "PMID": [
                        "9187685"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF73": {
                "ref_id": "b73",
                "title": "Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction",
                "authors": [
                    {
                        "first": "R",
                        "middle": [
                            "C"
                        ],
                        "last": "Rosen",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "C"
                        ],
                        "last": "Cappelleri",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [
                            "D"
                        ],
                        "last": "Smith",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [],
                        "last": "Lipsky",
                        "suffix": ""
                    },
                    {
                        "first": "B",
                        "middle": [
                            "M"
                        ],
                        "last": "Pena",
                        "suffix": ""
                    }
                ],
                "year": 1999,
                "venue": "International Journal of Impotence Research",
                "volume": "11",
                "issue": "6",
                "pages": "319--326",
                "other_ids": {
                    "PMID": [
                        "10637462"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF75": {
                "ref_id": "b75",
                "title": "The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population",
                "authors": [
                    {
                        "first": "R",
                        "middle": [
                            "C"
                        ],
                        "last": "Rosen",
                        "suffix": ""
                    },
                    {
                        "first": "W",
                        "middle": [
                            "A"
                        ],
                        "last": "Fisher",
                        "suffix": ""
                    },
                    {
                        "first": "I",
                        "middle": [],
                        "last": "Eardley",
                        "suffix": ""
                    },
                    {
                        "first": "C",
                        "middle": [],
                        "last": "Niederberger",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Nadel",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [],
                        "last": "Sand",
                        "suffix": ""
                    }
                ],
                "year": 2004,
                "venue": "Current Medical Research and Opinion",
                "volume": "20",
                "issue": "5",
                "pages": "607--617",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF77": {
                "ref_id": "b77",
                "title": "Minimal clinically important di erences in the erectile function domain of the International Index of Erectile Function Scale",
                "authors": [
                    {
                        "first": "R",
                        "middle": [
                            "C"
                        ],
                        "last": "Rosen",
                        "suffix": ""
                    },
                    {
                        "first": "K",
                        "middle": [
                            "R"
                        ],
                        "last": "Allen",
                        "suffix": ""
                    },
                    {
                        "first": "X",
                        "middle": [],
                        "last": "Ni",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [
                            "B"
                        ],
                        "last": "Araujo",
                        "suffix": ""
                    }
                ],
                "year": 2011,
                "venue": "European Urology",
                "volume": "60",
                "issue": "",
                "pages": "1010--1016",
                "other_ids": {
                    "PMID": [
                        "21855209"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF79": {
                "ref_id": "b79",
                "title": "Trends in CPAP adherence over twenty years of data collection: a flattened curve",
                "authors": [
                    {
                        "first": "B",
                        "middle": [
                            "W"
                        ],
                        "last": "Rotenberg",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [],
                        "last": "Murariu",
                        "suffix": ""
                    },
                    {
                        "first": "K",
                        "middle": [
                            "P"
                        ],
                        "last": "Pang",
                        "suffix": ""
                    }
                ],
                "year": 2016,
                "venue": "Journal of Otolaryngology",
                "volume": "45",
                "issue": "1",
                "pages": "1--9",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF81": {
                "ref_id": "b81",
                "title": "Erectile dysfunction and obstructive sleep apnea syndrome",
                "authors": [
                    {
                        "first": "T",
                        "middle": [],
                        "last": "Santos",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [],
                        "last": "Drummond",
                        "suffix": ""
                    },
                    {
                        "first": "F",
                        "middle": [],
                        "last": "Botelho",
                        "suffix": ""
                    }
                ],
                "year": 2012,
                "venue": "Portuguese Journal of Pulmonology",
                "volume": "18",
                "issue": "2",
                "pages": "64--71",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF83": {
                "ref_id": "b83",
                "title": "A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions",
                "authors": [
                    {
                        "first": "A",
                        "middle": [
                            "M"
                        ],
                        "last": "Sawyer",
                        "suffix": ""
                    },
                    {
                        "first": "N",
                        "middle": [
                            "S"
                        ],
                        "last": "Gooneratne",
                        "suffix": ""
                    },
                    {
                        "first": "C",
                        "middle": [
                            "L"
                        ],
                        "last": "Marcus",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [],
                        "last": "Ofer",
                        "suffix": ""
                    },
                    {
                        "first": "K",
                        "middle": [
                            "C"
                        ],
                        "last": "Richards",
                        "suffix": ""
                    },
                    {
                        "first": "T",
                        "middle": [
                            "E"
                        ],
                        "last": "Weaver",
                        "suffix": ""
                    }
                ],
                "year": 2011,
                "venue": "Sleep Medicine Reviews",
                "volume": "15",
                "issue": "6",
                "pages": "343--356",
                "other_ids": {
                    "PMID": [
                        "21652236"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF85": {
                "ref_id": "b85",
                "title": "E ect of CPAP therapy on endothelial function in obstructive sleep apnoea: a systematic review and meta-analysis",
                "authors": [
                    {
                        "first": "E",
                        "middle": [
                            "I"
                        ],
                        "last": "Schwarz",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [
                            "A"
                        ],
                        "last": "Puhan",
                        "suffix": ""
                    },
                    {
                        "first": "C",
                        "middle": [],
                        "last": "Schlatzer",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "R"
                        ],
                        "last": "Stradling",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [],
                        "last": "Kohler",
                        "suffix": ""
                    }
                ],
                "year": 2015,
                "venue": "Respirology",
                "volume": "20",
                "issue": "6",
                "pages": "889--895",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF87": {
                "ref_id": "b87",
                "title": "Erectile dysfunction and symptoms of sleep disorders",
                "authors": [
                    {
                        "first": "Se",
                        "middle": [],
                        "last": "El",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [
                            "D"
                        ],
                        "last": "Strohl",
                        "suffix": ""
                    },
                    {
                        "first": "K",
                        "middle": [
                            "P"
                        ],
                        "last": "Loye",
                        "suffix": ""
                    },
                    {
                        "first": "T",
                        "middle": [
                            "L"
                        ],
                        "last": "Bayard",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [],
                        "last": "Kress",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [],
                        "last": "Netzer",
                        "suffix": ""
                    },
                    {
                        "first": "N",
                        "middle": [
                            "C"
                        ],
                        "last": "",
                        "suffix": ""
                    }
                ],
                "year": 2002,
                "venue": "Sleep",
                "volume": "25",
                "issue": "6",
                "pages": "643--647",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF89": {
                "ref_id": "b89",
                "title": "Erectile dysfunction",
                "authors": [
                    {
                        "first": "R",
                        "middle": [],
                        "last": "Shamloul",
                        "suffix": ""
                    },
                    {
                        "first": "H",
                        "middle": [],
                        "last": "Ghanem",
                        "suffix": ""
                    }
                ],
                "year": 2013,
                "venue": "Lancet",
                "volume": "381",
                "issue": "",
                "pages": "153--165",
                "other_ids": {
                    "PMID": [
                        "23040455"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF91": {
                "ref_id": "b91",
                "title": "Erectile dysfunction and disease-specific quality of life in patients with obstructive sleep apnea",
                "authors": [
                    {
                        "first": "H",
                        "middle": [
                            "W"
                        ],
                        "last": "Shin",
                        "suffix": ""
                    },
                    {
                        "first": "Y",
                        "middle": [
                            "C"
                        ],
                        "last": "Rha",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [
                            "H"
                        ],
                        "last": "Han",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [],
                        "last": "Chung",
                        "suffix": ""
                    },
                    {
                        "first": "I",
                        "middle": [
                            "Y"
                        ],
                        "last": "Yoon",
                        "suffix": ""
                    },
                    {
                        "first": "C",
                        "middle": [
                            "S"
                        ],
                        "last": "Rhee",
                        "suffix": ""
                    }
                ],
                "year": 2008,
                "venue": "International Journal of Impotence Research",
                "volume": "20",
                "issue": "6",
                "pages": "549--553",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF93": {
                "ref_id": "b93",
                "title": "Sympathetic neural mechanisms in obstructive sleep apnea",
                "authors": [
                    {
                        "first": "V",
                        "middle": [
                            "K"
                        ],
                        "last": "Somers",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [
                            "E"
                        ],
                        "last": "Dyken",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [
                            "P"
                        ],
                        "last": "Clary",
                        "suffix": ""
                    },
                    {
                        "first": "F",
                        "middle": [
                            "M"
                        ],
                        "last": "Abboud",
                        "suffix": ""
                    }
                ],
                "year": 1995,
                "venue": "Journal of Clinical Investigation",
                "volume": "96",
                "issue": "4",
                "pages": "1897--1904",
                "other_ids": {
                    "PMID": [
                        "7560081"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF94": {
                "ref_id": "b94",
                "title": "Diagnostic and statistical manual of mental disorders 5: a quick glance",
                "authors": [
                    {
                        "first": ";",
                        "middle": [],
                        "last": "Vahia",
                        "suffix": ""
                    },
                    {
                        "first": "V",
                        "middle": [
                            "N"
                        ],
                        "last": "Vahia",
                        "suffix": ""
                    }
                ],
                "year": 2013,
                "venue": "Cochrane Database of Systematic Reviews #2 MeSH DESCRIPTOR Sleep Apnea, Obstructive AND CENTRAL:TARGET #3 sleep near3 (apnoea* or apnoea*) AND CENTRAL:TARGET #4 (hypopnea* or hypopnoea*) AND CENTRAL:TARGET #OSA OR SHS OR OSAHS:TI,AB) AND CENTRAL:TARGET #6 (#1 OR #2 OR #3 OR #4 OR #5AND CENTRAL:TARGET #MeSH DESCRIPTOR Sexual Dysfunction, Physiological Explode All AND CENTRAL:TARGET #8 MeSH DESCRIPTOR Sexual Dysfunctions, Psychological Explode All AND CENTRAL:TARGET #",
                "volume": "55",
                "issue": "",
                "pages": "220--223",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF95": {
                "ref_id": "b95",
                "title": "NEAR3 (dysfunct* or disorder* or satisf* or problem* or symptom* or arousal",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF96": {
                "ref_id": "b96",
                "title": "International Index of Erectile Function AND CENTRAL:TARGET #13 impotent or impotence AND CENTRAL:TARGET #14",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF98": {
                "ref_id": "b98",
                "title": "sexual* OR erectile*) NEAR function* AND CENTRAL:TARGET #16 ejaculat* AND CENTRAL:TARGET #17 #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 AND CENTRAL",
                "authors": [],
                "year": null,
                "venue": "TARGET #18 #6 AND #17 AND CENTRAL:TARGET #19 (#AND (CENTRAL:TARGET) MEDLINE Ovid",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF99": {
                "ref_id": "b99",
                "title": "exp sleep apnoea, obstructive/ 2. (sleep adj3 (apnoea* or apnoea*)).tw",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF100": {
                "ref_id": "b100",
                "title": "ti",
                "authors": [
                    {
                        "first": "Osahs",
                        "middle": [],
                        "last": "Osa Or",
                        "suffix": ""
                    }
                ],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF101": {
                "ref_id": "b101",
                "title": "1-3 5. exp Sexual Dysfunction, Physiological/ 6. exp Sexual Dysfunctions, Psychological/ 7",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF102": {
                "ref_id": "b102",
                "title": "sexualadj3 (arousal or aversion",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF103": {
                "ref_id": "b103",
                "title": "International Index of Erectile Function",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF104": {
                "ref_id": "b104",
                "title": "exp Penile Erection/ 13",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF106": {
                "ref_id": "b106",
                "title": "ab,ti. 19. placebo.ab,ti. 20. dt.fs. 21. randomly.ab,ti. 22. trial.ab,ti. 23. groups",
                "authors": [],
                "year": null,
                "venue": "Animals",
                "volume": "",
                "issue": "25",
                "pages": "17--23",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF107": {
                "ref_id": "b107",
                "title": "exp sleep apnoea, obstructive/ 2. (sleep adj3 (apnoea* or apnoea*)).tw",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF108": {
                "ref_id": "b108",
                "title": "ti",
                "authors": [
                    {
                        "first": "Osahs",
                        "middle": [],
                        "last": "Osa Or",
                        "suffix": ""
                    }
                ],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF109": {
                "ref_id": "b109",
                "title": "1-3 5. exp Sexual Dysfunction, Physiological/ 6. exp Sexual Dysfunctions, Psychological/ 7",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF110": {
                "ref_id": "b110",
                "title": "sexualadj3 (arousal or aversion",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF111": {
                "ref_id": "b111",
                "title": "Non-invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea (Review) Copyright \u00a9 2023 The Cochrane Collaboration",
                "authors": [],
                "year": null,
                "venue": "International Index of Erectile Function",
                "volume": "11",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF112": {
                "ref_id": "b112",
                "title": "exp Penile Erection/ 13",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF114": {
                "ref_id": "b114",
                "title": "randomisation/ 19. controlled clinical trial/ 20. Double Blind Procedure/ 21",
                "authors": [],
                "year": null,
                "venue": "Single Blind Procedure",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF115": {
                "ref_id": "b115",
                "title": "singl$ or doubl$ or trebl$ or tripl$) adj3 (mask$ or blind$ or method",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF116": {
                "ref_id": "b116",
                "title": "control$ or prospectiv$) adj3 (",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF117": {
                "ref_id": "b117",
                "title": "crossover$ or cross-over$)",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "17--29",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF118": {
                "ref_id": "b118",
                "title": "exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/ or nonhuman/ 32. human/ or normal human/ or human cell",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "33",
                "issue": "",
                "pages": "34--36",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF119": {
                "ref_id": "b119",
                "title": "sleep apnoea Search terms: sexual dysfunction OR sexual function OR erectile dysfunction OR",
                "authors": [],
                "year": null,
                "venue": "LILACS (sleep apnoea OR sleep apnoea or apnoea del sue\u00f1o or apn\u00e9ia do sono) AND (sexual dysfunction or disfunci\u00f3n sexual or disfun\u00e7\u00e3o sexual or erectile dysfunction or disfun\u00e7\u00e3o er\u00e9til or disfuncion er\u00e9ctil) ClinicalTrials.gov Study type: Interventional Condition: sleep apnoea Search terms: sexual dysfunction OR sexual function OR erectile dysfunction OR impotence WHO Trials portal Condition",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            }
        },
        "ref_entries": {
            "FIGREF0": {
                "text": "................................................................................................................................................................................................... PLAIN LANGUAGE SUMMARY....................................................................................................................................................................... SUMMARY OF FINDINGS.............................................................................................................................................................................. BACKGROUND.............................................................................................................................................................................................. OBJECTIVES.................................................................................................................................................................................................. METHODS..................................................................................................................................................................................................... Figure 1.................................................................................................................................................................................................. RESULTS........................................................................................................................................................................................................ Figure 2.................................................................................................................................................................................................. Figure 3.................................................................................................................................................................................................. Figure 4.................................................................................................................................................................................................. Figure 5.................................................................................................................................................................................................. DISCUSSION.................................................................................................................................................................................................. AUTHORS' CONCLUSIONS........................................................................................................................................................................... ACKNOWLEDGEMENTS................................................................................................................................................................................ REFERENCES................................................................................................................................................................................................ CHARACTERISTICS OF STUDIES.................................................................................................................................................................. DATA AND ANALYSES.................................................................................................................................................................................... Analysis 1.1.Comparison 1: CPAP versus no CPAP, Outcome 1: Erectile dysfunction...................................................................... Analysis 1.2.Comparison 1: CPAP versus no CPAP, Outcome 2: Sex-related quality of life.............................................................. Analysis 2.1.Comparison 2: CPAP versus phosphodiesterase type 5 (PDE5) inhibitors, Outcome 1: Erectile dysfunction............. Analysis 2.2.Comparison 2: CPAP versus phosphodiesterase type 5 (PDE5) inhibitors, Outcome 2: Sex-related quality of life (EDIT Q1)................................................................................................................................................................................................ Analysis 2.3.Comparison 2: CPAP versus phosphodiesterase type 5 (PDE5) inhibitors, Outcome 3: Minor adverse events........... APPENDICES................................................................................................................................................................................................. WHAT'S NEW................................................................................................................................................................................................. HISTORY........................................................................................................................................................................................................ CONTRIBUTIONS OF AUTHORS................................................................................................................................................................... DECLARATIONS OF INTEREST..................................................................................................................................................................... SOURCES OF SUPPORT............................................................................................................................................................................... DIFFERENCES BETWEEN PROTOCOL AND REVIEW.................................................................................................................................... INDEX TERMS...............................................................................................................................................................................................",
                "fig_num": null,
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "FIGREF2": {
                "text": "The Diagnostic and Statistical Manual of Mental Disorders (DSM-III, IV, IV R, or 5 (APA 2013; NIH Consens Statement Online 1992; Droller 1993; Vahia 2013)); \u2022 The American Urological Association (Montague 2005); \u2022 The World Health Organization (WHO 2010).",
                "fig_num": null,
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "FIGREF3": {
                "text": "Continuous positive airway pressure (CPAP) \u2022 Bilevel positive airway pressure (BiPAP) \u2022 Variable positive airway pressure (VPAP), or similar Comparators \u2022 Sham device \u2022 Drug therapy (sildenafil, tadalafil, vardenafil, mirodenafil, avanafil, lodenafil) \u2022 No intervention \u2022 Waiting list",
                "fig_num": null,
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "FIGREF4": {
                "text": "; Pascual 2018), sham (Melehan 2018) or phosphodiesterase type 5 inhibitors (Pastore 2014; Perimenis 2004; Perimenis 2007).The duration of intervention ranged from 4 weeks (Li 2004) to 12 weeks (Melehan 2018; Pascual 2018; Pastore 2014; Perimenis 2004; Perimenis 2007).",
                "fig_num": null,
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "FIGREF5": {
                "text": "Remission of ED: none of included RCTs assessed this outcome.However, all of them measured ED with a mean (SD) score on the International Index of Erectile Function (IIEF (Melehan 2018; Pascual 2018; Pastore 2014; Perimenis 2004; Perimenis 2007), or the IIEF-5 (Li 2004); \u2022 Serious adverse events: three RCTs (Li 2004; Perimenis 2004; Perimenis 2007); \u2022 Sex-related quality of life: one RCT assessed this outcome with the Erectile Dysfunction Index Treatment Satisfaction (EDITS (Melehan 2018)), two used EDITS Q1 (Pastore 2014; Perimenis 2007), one used the Self-esteem and RelationshipTest (SEAR (Pascual 2018)), and one used a single question with a dichotomous answer option (yes/no (Perimenis 2004)); \u2022 Health-related quality of life: one RCT assessed this outcome using the SF-36 (Melehan 2018); \u2022 Minor adverse events: two RCTs measured these (Perimenis 2004; Perimenis 2007).",
                "fig_num": null,
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "FIGREF6": {
                "text": "Figure 3. Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies Random sequence generation (selection bias) Allocation concealment (selection bias) Blinding of participants and personnel (performance bias): Remission of ED Blinding of participants and personnel (performance bias): Serious adverse events Blinding of participants and personnel (performance bias): Sex-related quality of life Blinding of participants and personnel (performance bias): Health-related quality of life Blinding of participants and personnel (performance bias): Minor adverse events Blinding of outcome assessment (detection bias): Remission of ED Blinding of outcome assessment (detection bias): Serious adverse events Blinding of outcome assessment (detection bias): Sex-related quality of life Blinding of outcome assessment (detection bias): Health-related quality of life Blinding of outcome assessment (detection bias): Minor adverse events Incomplete outcome data (attrition bias): Remission of ED Incomplete outcome data (attrition bias): Serious adverse events Incomplete outcome data (attrition bias): Sex-related quality of life Incomplete outcome data (attrition bias): Health-related quality of life Incomplete outcome data (attrition bias): Minor adverse events Selective reporting (reporting bias) Other bias",
                "fig_num": "3",
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "FIGREF7": {
                "text": "CPAP versus phosphodiesterase type 5 inhibitors Four RCTs assessed this comparison: three compared CPAP to sildenafil (Pastore 2014; Perimenis 2004; Perimenis 2007), and one compared it to vardenafil (Melehan 2018).",
                "fig_num": "3",
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "FIGREF8": {
                "text": "Figure 5. Forest plot of comparison: 1 CPAP versus phosphodiesterase type 5 inhibitors, outcome: 1.2 Sexualrelated quality of life (EDITS Q1).",
                "fig_num": null,
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "FIGREF9": {
                "text": "7 years \u2022 Sham CPAP (combined with both placebo or vardenafil): 52.6 \u00b1 10.4 years \u2022 Vardenalfil (combined with CPAP or sham CPAP): 54.5 \u00b1 9.5 years \u2022 Placebo (combined with CPAP or sham CPAP): 53.8 \u00b1 8.9 years Baseline imbalances: baseline characteristics for the 4 interventions groups not reported Subgroups measured: not reported Subgroups reported: not reported Interventions Number randomised in each group: \u2022 CPAP + vardenafil (N = 16): for CPAP, the individual pressure requirement was determined via a minimum 3-night home autotitration, using a Remstar Pro CPAP machine (Philips Respironics, Pittsburgh, PA). 10 mg vardenafil hydrochloride trihydrate (Levitra; GlaxoSmithKline, Warren, NJ), one tablet daily 1 hour before attempting to fall asleep, regardless of their intention to attempt sexual activity \u2022 CPAP + placebo (N = 15): for CPAP, the individual pressure requirement was determined via a minimum 3-night home autotitration using a Remstar Pro CPAP machine (Philips Respironics, Pittsburgh, PA).Placebo (Bayer Schering, Berlin, Germany), one tablet daily 1 hour before attempting to fall asleep, regardless of their intention to attempt sexual activity \u2022 Sham CPAP + vardenafil (N = 14): sham CPAP comprised an adapted machine and mask that ensured that the participant received sub-therapeutic (0.5 cm H O) therapy, but experienced all other facets of CPAP use \u2022 Sham CPAP + placebo (N = 16): sham CPAP comprised an adapted machine and mask that ensured that the participant received sub-therapeutic (0.5 cm H O) therapy, but experienced all other facets of CPAP use.Placebo (Bayer Schering, Berlin, Germany), one tablet daily 1 hour before attempting to fall asleep, regardless of their intention to attempt sexual activity Duration of treatment (follow-up): 12 weeks Outcomes Primary outcomes: \u2022 Erectile dysfunction, assessed by IIEF Melehan 2018 (Continued) Non-invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea (Review) Copyright \u00a9 2023 The Cochrane Collaboration.Published by John Wiley & Sons, Ltd.",
                "fig_num": null,
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "FIGREF10": {
                "text": "positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea (Review) Copyright \u00a9 2023 The Cochrane Collaboration.Published by John Wiley & Sons, Ltd.",
                "fig_num": null,
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "FIGREF11": {
                "text": "= 0.00; Chi\u00b2 = 0.03, df = 1 (P = 0.87); I\u00b2 = 0% Test for overall effect: Z = 4.28 (P < 0.0001) Test for subgroup differences: Not applicable applicable Test for overall effect: Z = 0.41 (P = 0.68) Test for subgroup differences: Not applicable positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea (Review) Copyright \u00a9 2023 The Cochrane Collaboration.Published by John Wiley & Sons, Ltd.",
                "fig_num": null,
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "TABREF0": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Serious adverse events</td><td colspan=\"2\">Not measured Risk with PDE5 in-</td><td/><td>Risk with CPAP device</td><td/><td>-</td><td>-</td></tr><tr><td/><td colspan=\"2\">hibitors</td><td/><td/><td/><td/></tr><tr><td>Sex-related quality of life</td><td/><td>-</td><td>-</td><td>-</td><td/><td>61 (1 RCT)</td><td>-</td><td>We were unable to extract this</td></tr><tr><td colspan=\"4\">Erectile dysfunction assessed with EDIT (scale 0 to 44; high-The mean IIEF-ED scores er scores = better functioning) follow-up: 12 weeks function) across control groups 30; lower scores = worse erectile ranged from 12.9 to 18.3 assessed with IIEF-ED (scale 0 to with PDE5 inhibitors</td><td>The mean IIEF-ED score (6.98 lower to 2.58 lower) points lower with CPAP device was 4.78</td><td>-</td><td/><td>152 (3 RCTs)</td><td>outcome for this comparison due \u2295\u2295\u229d\u229d MD -4.78 (-6.98 to the factorial design and re-porting of the trial. Low a to -2.58)</td></tr><tr><td>Health-related quality of life as-follow-up: 12 weeks</td><td/><td>-</td><td>-</td><td>-</td><td/><td>61 (1 RCT)</td><td>-</td><td>We were unable to extract this</td></tr><tr><td>sessed with SF-36 (scale 0 to 100 for</td><td/><td/><td/><td/><td/><td/><td>outcome for this comparison due</td></tr><tr><td>each domain; higher scores = better Serious adverse events</td><td colspan=\"2\">0 per 100</td><td/><td>0 per 100</td><td>-</td><td/><td>40</td><td>to the factorial design and re-\u2295\u229d\u229d\u229d -</td></tr><tr><td>functioning) follow-up: 12 weeks</td><td/><td/><td/><td>(0 to 0)</td><td/><td/><td>(1 RCT)</td><td>porting of the trial. Very low a,b</td></tr><tr><td>follow-up: 12 weeks</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Sex-related quality of life (QoL)</td><td colspan=\"2\">The mean scores from</td><td/><td>The mean EDITs -Q1 score</td><td>-</td><td/><td>122</td><td>\u2295\u229d\u229d\u229d</td><td>MD -1.24 (-1.80</td></tr><tr><td>5; higher = better) assessed with EDITS -Q1; scale 1 to</td><td colspan=\"3\">ranged from 3.5 to 3.7 QoL with PDE5 inhibitors EDITS -Q1 for sex-related</td><td>(1.8 lower to 0.67 lower) CPAP devu was 1.24 points lower with</td><td/><td/><td>(2 RCTs)</td><td>Very low a,c</td><td>to -0.67)</td></tr><tr><td>follow-up: 12 weeks</td><td colspan=\"2\">across control groups</td><td/><td/><td/><td/></tr><tr><td>Health-related quality of life</td><td colspan=\"2\">Not reported</td><td/><td/><td/><td/><td>-</td><td>-</td></tr><tr><td colspan=\"8\">1 higher) (95% CI) Relative effect *The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and -57 (1 RCT) \u2295\u229d\u229d\u229d Very low c,d MD 2.50 (-1.10 to 6.10) Serious adverse events (95% CI) pants the evidence follow-up: 4 weeks 0 per 100 0 per 100 27 (1 RCT) \u2295\u229d\u229d\u229d Very low e,f -Outcomes \u2116 of partici-Certainty of Comments Minor adverse events 15 per 100 20 per 100 (5 to 78) RR 1.33 (0.34 to 5.21) 40 (1 RCT) \u2295\u229d\u229d\u229d Very low a,d Summary Anticipated absolute effects * its 95% CI).</td></tr><tr><td colspan=\"2\">Sex-related quality of life (QoL) assessed withchange in SEAR (scale 1 to 14; higher scores = better functioning) Erectile dysfunction</td><td colspan=\"3\">The mean sex-re-lated QoL score without CPAP was Risk with sham Risk with CPAP The mean sex-related QoL score with CPAP device was CPAP device 1 point higher 3.0 points (8.09 lower to 10.09 higher) ---</td><td>-</td><td>(studies) 61 (1 RCT)</td><td>57 (1 RCT) (GRADE) -</td><td>\u2295\u229d\u229d\u229d Very low c,d We were unable to extract this MD 1.00 (-8.09 to 10.09)</td></tr><tr><td>follow-up: 12 weeks Health-related quality of life assessed with IIEF (scale 0 to 75; high-er scores = better functioning)</td><td/><td>not measured</td><td/><td/><td/><td/><td>-</td><td>-</td><td>outcome for this comparison due to the factorial design and re-porting of the trial.</td></tr><tr><td>Minor adverse events follow-up: 12 weeks</td><td/><td>not measured</td><td/><td/><td/><td/><td>-</td><td>-</td></tr></table>",
                "type_str": "table"
            },
            "TABREF1": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table/>",
                "type_str": "table"
            },
            "TABREF4": {
                "text": "by a specific validated tool, such as the Psychometric validation of a sexual quality of life questionnaire for use in men with erectile dysfunction (Abraham 2009).\u2022 Health-related quality of life: measured by a general validated tool, such as the Health Assessment Questionnaire (HAQ (Wolfe 1994)), and the Health Survey Questionnaire (SF-36 (Ware",
                "html": null,
                "num": null,
                "content": "<table/>",
                "type_str": "table"
            },
            "TABREF5": {
                "text": "Cochrane Central Register of Controlled Trials (CENTRAL), via the Cochrane Register of Studies (searched 14 June 2021); \u2022 MEDLINE Ovid SP (1946 to 14 June 2021); \u2022 Embase Ovid SP (1974 to 14 June 2021); \u2022 LILACS (Literatura Latino-Americana em Ci\u00eancias de Sa\u00fade; 1982 to 14 June 2021); \u2022 US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov(www.clinicaltrials.gov;searched 14 June 2021); \u2022 World Health Organization International Clinical Trials Registry Platform (apps.who.int/trialsearch;searched 14 June 2021).",
                "html": null,
                "num": null,
                "content": "<table/>",
                "type_str": "table"
            },
            "TABREF10": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td colspan=\"3\">Trusted evidence. Informed decisions. Better health.</td><td/><td/><td/><td/><td/><td colspan=\"2\">Cochrane Database of Systematic Reviews</td></tr><tr><td>Figure 4. Pastore 2014</td><td>11.7 Mean</td><td>CPAP 3.7 SD</td><td>Total</td><td>41</td><td colspan=\"2\">PDE5 inhibitors 18.3 4.9 Mean SD Total</td><td>41</td><td>40.2% Weight</td><td>Mean Difference -6.60 [-8.48 , -4.72] IV, Random, 95% CI</td><td>Mean Difference IV, Random, 95% CI</td></tr><tr><td>Perimenis 2004</td><td>9.3</td><td>3.3</td><td/><td>15</td><td>12.9</td><td>4</td><td>15</td><td>31.4%</td><td>-3.60 [-6.22 , -0.98]</td></tr><tr><td>Perimenis 2007</td><td>10.8</td><td>4.4</td><td/><td>20</td><td>14.3</td><td>5</td><td>20</td><td>28.4%</td><td>-3.50 [-6.42 , -0.58]</td></tr><tr><td>Total (95% CI)</td><td/><td/><td/><td>76</td><td/><td/><td>76</td><td>100.0%</td><td>-4.78 [-6.98 , -2.58]</td></tr><tr><td colspan=\"6\">Heterogeneity: Tau\u00b2 = 2.22; Chi\u00b2 = 4.85, df = 2 (P = 0.09); I\u00b2 = 59%</td><td/><td/><td/><td/></tr><tr><td colspan=\"3\">Test for overall effect: Z = 4.25 (P &lt; 0.0001)</td><td/><td/><td/><td/><td/><td/><td>-20</td><td>-10</td><td>0</td><td>10</td><td>20</td></tr><tr><td colspan=\"3\">Test for subgroup differences: Not applicable</td><td/><td/><td/><td/><td/><td/><td colspan=\"2\">Favours PDE5 inhibitors</td><td>Favours CPAP</td></tr><tr><td colspan=\"7\">Melehan 2018 measured this outcome with the IIEF-15 and IIEF-ED,</td><td/><td/><td/></tr><tr><td colspan=\"7\">but we were unable to extract separate data due to the factorial</td><td/><td/><td/></tr><tr><td colspan=\"2\">design and reporting of this trial.</td><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td/><td/><td/><td/><td/><td/><td/><td colspan=\"4\">Three RCTs measured this outcome using IIEF-ED and showed that</td></tr><tr><td/><td/><td/><td/><td/><td/><td/><td colspan=\"4\">sildenafil may slightly improve ED at 12 weeks when compared to</td></tr><tr><td/><td/><td/><td/><td/><td/><td/><td colspan=\"4\">CPAP (MD -4.78, 95% CI -6.98 to -2.58; three RCTs, 152 participants; I</td></tr><tr><td/><td/><td/><td/><td/><td/><td/><td colspan=\"4\">= 59%; low-certainty evidence, downgraded due to methodological</td></tr><tr><td/><td/><td/><td/><td/><td/><td/><td colspan=\"4\">limitations; Analysis 2.1; Figure 4) (Pastore 2014; Perimenis 2004;</td></tr><tr><td/><td/><td/><td/><td/><td/><td/><td colspan=\"3\">Perimenis 2007) .</td></tr></table>",
                "type_str": "table"
            },
            "TABREF13": {
                "text": "\"Subjects were selected from the ED patients who came to our hospital from April 2000 to September 2002.27 patients with OSAS were detected by polysomnography, aged 28 to 68 years, with an average age of 39.8 years.\"",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health. Trusted evidence. Informed decisions. Better health.</td><td>Cochrane Database of Systematic Reviews</td></tr><tr><td>Li 2004 (Continued)</td><td/><td/></tr><tr><td/><td colspan=\"2\">Method of recruitment: not reported</td></tr><tr><td/><td colspan=\"2\">Inclusion criteria: Exclusion criteria: not reported</td></tr><tr><td/><td colspan=\"2\">Withdrawals and exclusions: no</td></tr><tr><td/><td colspan=\"2\">Mean age (years; mean, SD): 28 to 68 years, with a mean age of 39.8 years</td></tr><tr><td/><td colspan=\"2\">Baseline imbalances: not reported</td></tr><tr><td/><td colspan=\"2\">Subgroups measured: not reported</td></tr><tr><td/><td colspan=\"2\">Subgroups reported: not reported</td></tr><tr><td>Interventions</td><td colspan=\"2\">Number randomised in each group:</td></tr><tr><td/><td colspan=\"2\">Intention-to-treat analysis: CPAP: 15 men; no CPAP: 12 men</td></tr><tr><td/><td colspan=\"2\">Dose CPAP group: treatment was 5 consecutive nights from Monday to Friday, from 22.00 to 6.00, for 4</td></tr><tr><td/><td>consecutive weeks</td><td/></tr><tr><td/><td colspan=\"2\">Dose no CPAP group: control group was not treated with a ventilator, but slept in the observation</td></tr><tr><td/><td colspan=\"2\">room under the same conditions as the treatment group</td></tr><tr><td/><td>Follow-up: 4 weeks</td><td/></tr><tr><td>Outcomes</td><td colspan=\"2\">Outcomes: (not reported as primary or secondary outcomes)</td></tr><tr><td/><td>-AHI</td><td/></tr><tr><td/><td>-the lowest SatO 2</td><td/></tr><tr><td/><td colspan=\"2\">-IIEF (also called IIEF-15)</td></tr><tr><td/><td>-serious adverse events</td><td/></tr><tr><td/><td colspan=\"2\">Imputation of missing data: not reported</td></tr><tr><td colspan=\"2\">Notes Funding Random sequence genera-Unclear risk</td><td>Quote: \"Twenty-seven patients with ED and OSAS were randomly divided into</td></tr><tr><td>tion (selection bias)</td><td/><td>treatment (N = 15) and control (N = 12) groups.\"</td></tr><tr><td/><td/><td>Comments: the method was not described</td></tr><tr><td>Allocation concealment</td><td>Unclear risk</td><td>Comments: the method was not described</td></tr><tr><td>(selection bias)</td><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF14": {
                "text": "\u2022 Vardenalfil (combined with CPAP or sham CPAP) versus placebo (combined with CPAP or sham CPAP)",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health.</td><td>Cochrane Database of Systematic Reviews</td></tr><tr><td/><td>Start date: 1 May 2010</td><td/></tr><tr><td/><td>End date: 15 March 2013</td><td/></tr><tr><td/><td colspan=\"2\">Ethical approval: study protocol was approved by the Human Research Ethics Committee, Concord</td></tr><tr><td/><td colspan=\"2\">Repatriation General Hospital (Concord, New South Wales, Australia) and Monash Health Human Re-</td></tr><tr><td/><td colspan=\"2\">search Ethics Committee (Clayton, Victoria, Australia). All participants provided written informed con-</td></tr><tr><td/><td>sent.</td><td/></tr><tr><td>Participants</td><td>Total number randomised/available for analysis: 61/55</td><td/></tr><tr><td/><td>Method of recruitment: not reported</td><td/></tr><tr><td/><td colspan=\"2\">Inclusion criteria: 18 to 65 years; AHI &gt; 20; oxygen desaturation index 3% or greater; &gt; 15 events/hour;</td></tr><tr><td/><td colspan=\"2\">erectile dysfunction, defined as IIEF, Erectile Dysfunction domain score &lt; 26; must have been in a stable</td></tr><tr><td/><td>relationship for at least six months; must be CPAP naive</td><td/></tr><tr><td>Melehan 2018</td><td/><td/></tr><tr><td/><td>Unit of allocation: by individuals</td><td/></tr><tr><td/><td>Run-in: not reported</td><td/></tr><tr><td/><td>Washout: not reported</td><td/></tr><tr><td/><td colspan=\"2\">Setting: the Woolcock Institute of Medical Research (Sydney, New South Wales, Australia) and Monash</td></tr><tr><td/><td>Medical Centre Sleep Unit (Clayton, Victoria, Australia)</td><td/></tr><tr><td/><td>Country: Australia</td><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF16": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Melehan 2018 (Continued)</td><td/><td/></tr><tr><td>Random sequence genera-</td><td>Low risk</td><td>Quote: \"The randomisation sequence was generated by computer program</td></tr><tr><td>tion (selection bias)</td><td/><td>(the blockrand function in R) using random permuted blocks. Separate se-</td></tr><tr><td/><td/><td>quences were generated to achieve stratification by the two study centres.\"</td></tr><tr><td/><td/><td>Comments: the method was described and seemed adequate</td></tr><tr><td>Allocation concealment</td><td>Low risk</td><td>Quote: \"Printed cards allocating CPAP or sham were labelled sequentially by</td></tr><tr><td>(selection bias)</td><td/><td>randomisation number and placed in opaque, sealed envelopes by an individ-</td></tr><tr><td/><td/><td>ual independent of the study sta or investigators. CPAP machine preparation,</td></tr><tr><td/><td/><td>download, and troubleshooting was performed by personnel separate to the</td></tr><tr><td/><td/><td>study investigators and not involved in participant assessments.</td></tr><tr><td/><td/><td>Comments: the method was described and seemed adequate</td></tr><tr><td>Blinding of participants</td><td>Low risk</td><td>Quote: \"CPAP machine preparation, download, and troubleshooting was per-</td></tr><tr><td>and personnel (perfor-</td><td/><td>formed by personnel separate to the study investigators and not involved in</td></tr><tr><td>mance bias)</td><td/><td>participant assessments. A trial pharmacist who was not otherwise involved</td></tr><tr><td>Remission of ED</td><td/><td>with the study prepared the study medication (vardenafil or placebo) in identi-</td></tr><tr><td/><td/><td>cally appearing bottles labelled by randomisation number using the generated</td></tr><tr><td/><td/><td>allocation list. The participants and study investigators were blinded to treat-</td></tr><tr><td/><td/><td>ment allocation (and adherence) for the duration of the trial\"</td></tr><tr><td/><td/><td>Comments: the method was described and seemed adequate</td></tr><tr><td>Non-</td><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF17": {
                "text": "Copyright \u00a9 2023 The Cochrane Collaboration.Published by John Wiley & Sons, Ltd.CPAP machine preparation, download, and troubleshooting was performed by personnel separate to the study investigators and not involved in participant assessments.A trial pharmacist who was not otherwise involved with the study prepared the study medication (vardenafil or placebo) in identically appearing bottles labelled by randomisation number using the generated allocation list.The participants and study investigators were blinded to treatment allocation (and adherence) for the duration of the trial\" CPAP machine preparation, download, and troubleshooting was performed by personnel separate to the study investigators and not involved in participant assessments.A trial pharmacist who was not otherwise involved with the study prepared the study medication (vardenafil or placebo) in identically appearing bottles labelled by randomisation number using the generated allocation list.The participants and study investigators were blinded to treatment allocation (and adherence) for the duration of the trial\"",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Library Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health. Trusted evidence. Informed decisions. Better health.</td><td>Cochrane Database of Systematic Reviews Cochrane Database of Systematic Reviews</td></tr><tr><td>Melehan 2018 (Continued) Melehan 2018 (Continued)</td><td/><td/></tr><tr><td>Blinding of participants and personnel (perfor-mance bias) Sex-related quality of life Incomplete outcome data (attrition bias) Health-related quality of life Selective reporting (re-porting bias)</td><td>Low risk Low risk High risk</td><td>Comments: Low rate of loss (less than 10%) Quote: \"61 men were randomised into the study. Six men withdrew from the study after randomisation; therefore, 55 men completed both the CPAP and vardenafil studies.\" Comments: Low rate of loss (less than 10%) Comments: not all pre-planned time points for the primary outcome were re-Quote: \"Comments: the method was described and seemed adequate ported (4 and 8 weeks), not even in the supplementary material. The author</td></tr><tr><td>Blinding of participants and personnel (perfor-</td><td>Low risk</td><td>did not report the data for the 4 groups of interventions, but instead, provided Quote: \"CPAP machine preparation, download, and troubleshooting was per-formed by personnel separate to the study investigators and not involved in the data combined in pair of interventions. Protocol available from</td></tr><tr><td>mance bias) Health-related quality of life</td><td/><td>participant assessments. A trial pharmacist who was not otherwise involved www.anzctr.org.au, number 335130. Sexual-related and health-related quality with the study prepared the study medication (vardenafil or placebo) in identi-cally appearing bottles labelled by randomisation number using the generated of life were measured but not reported for all comparisons.</td></tr><tr><td>Other bias</td><td>Low risk</td><td>allocation list. The participants and study investigators were blinded to treat-ment allocation (and adherence) for the duration of the trial\" The study seems to be free of other sources of bias.</td></tr><tr><td/><td/><td>Comments: the method was described and seemed adequate</td></tr><tr><td>Blinding of outcome as-sessment (detection bias) Remission of ED</td><td>Low risk</td><td>Quote: \"Comments: the method was described and seemed adequate</td></tr><tr><td>Blinding of outcome as-</td><td>Low risk</td><td>Quote: \"CPAP machine preparation, download, and troubleshooting was per-</td></tr><tr><td>sessment (detection bias)</td><td/><td>formed by personnel separate to the study investigators and not involved in</td></tr><tr><td>Sex-related quality of life</td><td/><td>participant assessments. A trial pharmacist who was not otherwise involved</td></tr><tr><td/><td/><td>with the study prepared the study medication (vardenafil or placebo) in identi-</td></tr><tr><td/><td/><td>cally appearing bottles labelled by randomisation number using the generated</td></tr><tr><td/><td/><td>allocation list. The participants and study investigators were blinded to treat-</td></tr><tr><td/><td/><td>ment allocation (and adherence) for the duration of the trial\"</td></tr><tr><td/><td/><td>Comments: the method was described and seemed adequate</td></tr><tr><td>Blinding of outcome as-</td><td>Low risk</td><td>Quote: \"CPAP machine preparation, download, and troubleshooting was per-</td></tr><tr><td>sessment (detection bias)</td><td/><td>formed by personnel separate to the study investigators and not involved in</td></tr><tr><td>Health-related quality of</td><td/><td>participant assessments. A trial pharmacist who was not otherwise involved</td></tr><tr><td>life</td><td/><td>with the study prepared the study medication (vardenafil or placebo) in identi-</td></tr><tr><td/><td/><td>cally appearing bottles labelled by randomisation number using the generated</td></tr><tr><td/><td/><td>allocation list. The participants and study investigators were blinded to treat-</td></tr><tr><td/><td/><td>ment allocation (and adherence) for the duration of the trial\"</td></tr><tr><td/><td/><td>Comments: the method was described and seemed adequate</td></tr><tr><td>Incomplete outcome data</td><td>Low risk</td><td>Quote: \"61 men were randomised into the study. Six men withdrew from the</td></tr><tr><td>(attrition bias)</td><td/><td>study after randomisation; therefore, 55 men completed both the CPAP and</td></tr><tr><td>Remission of ED</td><td/><td>vardenafil studies.\"</td></tr><tr><td/><td/><td>Comments: Low rate of loss (less than 10%)</td></tr><tr><td>Incomplete outcome data</td><td>Low risk</td><td>Quote: \"61 men were randomised into the study. Six men withdrew from the</td></tr><tr><td>(attrition bias)</td><td/><td>study after randomisation; therefore, 55 men completed both the CPAP and</td></tr><tr><td>Sex-related quality of life</td><td/><td>vardenafil studies.\"</td></tr></table>",
                "type_str": "table"
            },
            "TABREF18": {
                "text": "The ethics committee of Hospital Univ Arnau de Vilanova approved the study(CEIC-996; 27 March 2012), and all participants provided written informed consent",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Participants</td><td>Total number randomised/available for analysis: 75/57</td></tr><tr><td/><td>Method of recruitment: cross-sectional study considering consecutive male patients newly diagnosed</td></tr><tr><td/><td>with moderate to severe OSAS, aged 18 to 70 years, in a current relationship, who were attending the</td></tr><tr><td/><td>sleep unit of Hospital Univ Arnau de Vilanova-Santa Maria, Spain, between 1 April 2013 and 31 July</td></tr><tr><td/><td>2016</td></tr><tr><td/><td>Inclusion criteria: men, newly diagnosed with moderate to severe OSAS, aged 18 to 70 years, in a cur-</td></tr><tr><td/><td>rent relationship; including only those men with OSAS who were diagnosed with ED</td></tr></table>",
                "type_str": "table"
            },
            "TABREF19": {
                "text": "Copyright \u00a9 2023 The Cochrane Collaboration.Published by John Wiley & Sons, Ltd.Cochrane Database of Systematic Reviews schizophrenia, bipolar disorder, chronic renal failure, and inflammatory bowel disease); pelvic surgery (radical prostatectomy); congenital or acquired malformations (Peyronie's disease, hypospadias, epispadias, and penile fracture); hormonal alterations (hypogonadism, hyperprolactinaemia, hyper-or hypothyroidism, and Cushing's disease); and drug abuse(alcohol, cocaine, and heroin)",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health.</td></tr><tr><td/><td>Withdrawals and exclusions: 18 men</td></tr><tr><td/><td>Mean age (years, mean, SD): 54.8 years (SD 1.00)</td></tr></table>",
                "type_str": "table"
            },
            "TABREF20": {
                "text": "Subgroups reported: regardless of statistical significance, dose-response relationships could be seen for erectile function and sexual satisfaction when considering 3 CPAP compliance categories: nonusers, user below median (5.3 h/night), and users above median (Table A in S1 Additional results).CPAP titration was performed using an auto-CPAP device (Autoset-T, ResMed, Sydney, Australia), previously validated by the Spanish Sleep and Breathing Group.The optimal pressure was assessed by visually analysing the pressure curve, which included the periods with a leak lower than 0.4 L/s (90th centile).At-home treatment was initiated with a fixed CPAP level after the optimal pressure was determined.acknowledgedfundingfromRafaelMolla y Rodrigo 2012 clinical research grant (Fundacion investigacion Urolog\u0131a, Asociacion Espa\u00f1ola de Urolog\u0131a, Spain); and, SEPAR 2011 research grant (Spanish Society of Pneumology and Thoracic Surgery -SEPAR).The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.Method of recruitment: 82 men who had been referred to the outpatient clinic for sleep disorders between January 2011 and February 2012; all men presented with ED and were proven to suffer from OSAS Inclusion criteria: men with severe OSAS, that is, those who had an AHI of more than 30 events/h, as evidenced by a full polysomnography performed no later than 6 months from the start of the treatment Exclusion criteria: men with ED treated with medication or intracavernous injections, blood hypertension (systolic blood pressure above 160 mmHg; diastolic blood pressure above 100 mmHg), use of nitrates, diabetes mellitus, vascular diseases (deep vein thrombosis, peripheral vascular disease, Raynaud's disease, vasculitis syndromes), mild and moderate OSAS (AHI less than 30 events per hour), peripheral neuropathic disease, prostate cancer, pelvic trauma history, renal transplantation, aortic aneurysm, spinal cord injury, a BMI > 30 kg/m2, endocrine disturbances, penile deformity, current alcohol or drug abuse, or medications that could affect erection such as beta blockers or H 2 blockers.Baseline imbalances: treatment groups were similar for demographical characteristics (Table1), severity of OSAS, mean scores for the erectile function domain of the IIEF",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health.</td><td>Cochrane Database of Systematic Reviews</td></tr><tr><td/><td>Subgroups measured: not reported</td><td/></tr><tr><td/><td>Withdrawals and exclusions: 0 participants</td><td/></tr><tr><td/><td colspan=\"2\">Mean age (years, mean, SD): CPAP arm 48.6 + 8.5; sildenafil arm 47.4 + 9.8</td></tr><tr><td>Interventions</td><td>Number randomised in each group:</td><td/></tr><tr><td/><td>Intention to treat: CPAP: 40 men/no CPAP: 35 men</td><td/></tr><tr><td>Outcomes</td><td>Dose CPAP group: Dose No CPAP group: not reported Follow-up: 12 weeks Primary outcomes: Subgroups Follow-up: 12 weeks</td><td/></tr><tr><td/><td colspan=\"2\">\u2022 Change in IIEF-15 score (also named IIEF), but the author only reported the individual score for each</td></tr><tr><td>Outcomes</td><td>domain that comprised the overall score Outcomes:</td><td/></tr><tr><td/><td>Secondary outcomes: \u2022 IIEF-ED domain</td><td/></tr><tr><td/><td>\u2022 Sex Encounter Profile</td><td/></tr><tr><td/><td>\u2022 EDITS</td><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF21": {
                "text": "all authors certify that there are no conflicts of interest, including specific financial interests, and relationships and affiliations relevant to the subject or materials discussed in the manuscript (e.g.employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending)",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Pastore 2014 (Continued)</td><td/><td/></tr><tr><td>Notes</td><td colspan=\"2\">Funding sources: not supported by any Foundation</td></tr><tr><td/><td colspan=\"2\">Conflict of interest: Full text language: English</td></tr><tr><td/><td colspan=\"2\">Clinical trials register database: not reported</td></tr><tr><td>Risk of bias</td><td/><td/></tr><tr><td>Bias</td><td colspan=\"2\">Authors' judgement Support for judgement</td></tr><tr><td>Random sequence genera-</td><td>Low risk</td><td>Quote: \"Randomisation was made using a computer table generation of ran-</td></tr><tr><td>tion (selection bias)</td><td/><td>dom numbers.\"</td></tr><tr><td>Non-</td><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF22": {
                "text": "Copyright \u00a9 2023 The Cochrane Collaboration.Published by John Wiley & Sons, Ltd. was no mention of any attempt at blinding, by using placebo or sham CPAP, and the outcome is likely to be influenced by lack of blinding Blinding can be impossible for at least some people.wasnomention of any attempt at blinding, by using placebo or sham CPAP, and the outcome is likely to be influenced by lack of blinding Blinding of outcome assessment (detection bias) Remission of EDHigh riskComment: there was no mention of any attempt at blinding, by using placebo or sham CPAP, and the outcome is likely to be influenced by lack of blinding Blinding of outcome assessment (detection bias) Sex-related quality of life High risk Comment: there was no mention of any attempt at blinding, by using placebo or sham CPAP, and the outcome is likely to be influenced by lack of blinding to compare the efficacy of sildenafil and CPAP in men with erectile dysfunction and OSAS",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health.</td><td>Cochrane Database of Systematic Reviews</td></tr><tr><td>Pastore 2014 (Continued)</td><td/><td/></tr><tr><td/><td/><td>Comments: the method was described and seemed adequate</td></tr><tr><td>Allocation concealment</td><td>Unclear risk</td><td>Comments: methods adopted for ensuring allocation concealment were not</td></tr><tr><td>(selection bias)</td><td/><td>described</td></tr><tr><td colspan=\"3\">Blinding of participants and personnel (perfor-mance bias) Remission of ED Comment: there Blinding of participants High risk and personnel (perfor-mance bias) Sex-related quality of life High risk Comment: there Incomplete outcome data Low risk There were no losses.</td></tr><tr><td>(attrition bias)</td><td/><td/></tr><tr><td>Remission of ED</td><td/><td/></tr><tr><td>Incomplete outcome data</td><td>Low risk</td><td>There were no losses.</td></tr><tr><td>(attrition bias)</td><td/><td/></tr><tr><td>Sex-related quality of life</td><td/><td/></tr><tr><td>Selective reporting (re-</td><td>Unclear risk</td><td>No protocol was found.</td></tr><tr><td>porting bias)</td><td/><td/></tr><tr><td>Other bias</td><td>Low risk</td><td>The study seems to be free of other sources of bias.</td></tr><tr><td>Study characteristics</td><td/><td/></tr><tr><td>Methods</td><td>Aim of study: Study design: RCT</td><td/></tr><tr><td/><td colspan=\"2\">Study grouping: parallel group</td></tr><tr><td/><td colspan=\"2\">Unit of allocation: by individuals</td></tr><tr><td/><td>Run-in: not reported</td><td/></tr><tr><td/><td>Washout: not reported</td><td/></tr><tr><td/><td>Setting: not reported</td><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF23": {
                "text": "Copyright \u00a9 2023 The Cochrane Collaboration.Published by John Wiley & Sons, Ltd.",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td colspan=\"2\">Trusted evidence. Informed decisions. Better health.</td><td/><td colspan=\"2\">Cochrane Database of Systematic Reviews</td></tr><tr><td colspan=\"3\">D A T A A N D A N A L Y S E S</td><td/><td/></tr><tr><td/><td/><td colspan=\"2\">-Changes in IIEF domain scores</td><td/></tr><tr><td colspan=\"4\">-Related adverse events Comparison 1. CPAP versus no CPAP</td><td/></tr><tr><td colspan=\"2\">Outcome or subgroup title</td><td colspan=\"2\">Other outcome reported: not reported No. of studies No. of partici-</td><td>Statistical method</td><td>Effect size</td></tr><tr><td/><td/><td colspan=\"2\">Imputation of missing data: not reported pants</td><td/></tr><tr><td>Notes 1.1 Erectile dysfunction</td><td/><td colspan=\"2\">Funding sources: not reported 2</td><td>CI) Mean Difference (IV, Random, 95%</td><td>Subtotals only</td></tr><tr><td>1.1.1 4 weeks (IIEF-5)</td><td/><td>1</td><td>27</td><td>Mean Difference (IV, Random, 95%</td><td>7.50 [4.05, 10.95]</td></tr><tr><td/><td/><td/><td/><td>CI)</td></tr><tr><td>1.1.2 12 weeks (change in</td><td/><td>1</td><td>57</td><td>Mean Difference (IV, Random, 95%</td><td>2.50 [-1.10, 6.10]</td></tr><tr><td>IIEF-ED)</td><td/><td/><td/><td>CI)</td></tr><tr><td colspan=\"2\">1.2 Sex-related quality of life</td><td>1</td><td>57</td><td>Mean Difference (IV, Random, 95%</td><td>1.00 [-8.09, 10.09]</td></tr><tr><td/><td/><td/><td/><td>CI)</td></tr></table>",
                "type_str": "table"
            },
            "TABREF24": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td colspan=\"2\">Trusted evidence. Informed decisions. Better health.</td><td/><td/><td/><td/><td/><td>Cochrane Database of Systematic Reviews</td></tr><tr><td colspan=\"9\">Comparison 2. CPAP versus phosphodiesterase type 5 (PDE5) inhibitors</td></tr><tr><td colspan=\"2\">Outcome or subgroup title</td><td colspan=\"2\">No. of studies</td><td colspan=\"3\">No. of partici-</td><td colspan=\"2\">Statistical method</td><td>Effect size</td></tr><tr><td/><td/><td/><td/><td>pants</td><td/><td/><td/></tr><tr><td>2.1 Erectile dysfunction</td><td/><td>3</td><td/><td>152</td><td/><td/><td colspan=\"2\">Mean Difference (IV, Random,</td><td>-4.78 [-6.98, -2.58]</td></tr><tr><td/><td/><td/><td/><td/><td/><td/><td colspan=\"2\">95% CI)</td></tr><tr><td colspan=\"2\">2.2 Sex-related quality of life</td><td>2</td><td/><td>122</td><td/><td/><td colspan=\"2\">Mean Difference (IV, Random,</td><td>-1.24 [-1.80, -0.67]</td></tr><tr><td>(EDIT Q1)</td><td/><td/><td/><td/><td/><td/><td colspan=\"2\">95% CI)</td></tr><tr><td>2.3 Minor adverse events</td><td/><td>1</td><td/><td>40</td><td/><td/><td colspan=\"2\">Risk Ratio (M-H, Random, 95% CI) 1.33 [0.34, 5.21]</td></tr><tr><td/><td/><td colspan=\"7\">Analysis 2.1. Comparison 2: CPAP versus phosphodiesterase</td></tr><tr><td colspan=\"6\">CPAP 3.7 type 5 (PDE5) Pastore 2014 11.7 41 Mean SD Total Mean PDE5 inhibitors 18.3 4.9 SD Total</td><td>41</td><td>40.2% Weight</td><td>Mean Difference IV, Random, 95% CI</td></tr><tr><td>Perimenis 2004</td><td>9.3</td><td>3.3</td><td>15</td><td>12.9</td><td>4</td><td>15</td><td>31.4%</td></tr><tr><td>Perimenis 2007</td><td>10.8</td><td>4.4</td><td>20</td><td>14.3</td><td>5</td><td>20</td><td>28.4%</td></tr><tr><td>Total (95% CI)</td><td/><td/><td>76</td><td/><td/><td>76</td><td>100.0%</td></tr><tr><td colspan=\"5\">Heterogeneity: Tau\u00b2 = 2.22; Chi\u00b2 = 4.85, df = 2 (P = 0.09); I\u00b2 = 59%</td><td/><td/><td/></tr><tr><td colspan=\"3\">Test for overall effect: Z = 4.25 (P &lt; 0.0001)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"3\">Test for subgroup differences: Not applicable</td><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            }
        }
    }
}